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resumo 
 
 
Imunofilinas são receptores intracelulares de drogas imunossupressoras, como 
a ciclosporina A, FK506 e rapamicina, caracterizados por apresentarem
actividade de peptidil-prolil cis-trans isomerase. Além do seu envolvimento no 
enovelamento de proteínas, novos estudos demonstram o envolvimento destas
proteínas em processos celulares específicos como transdução de sinal, 
transporte e montagem de complexos proteícos e silenciamento de rDNA.
Neste estudo propusemo-nos caracterizar as funções celulares das
imunofilinas do tipo FKBP (FK506-binding proteins) identificadas em 
Neurospora crassa. Na procura pelo papel fisiológico destas proteínas
confirmamos a localização celular das proteínas FKBP12, FKBP22 e FKBP50
e determinamos a localização subcelular da proteína FKBP11. Foi também
analisada a expressão destas proteínas em resposta a diversos indutores de 
stress, realizadas imunoprecipitações e produzidos e analisados mutantes
simples e duplos para os genes fkbp. Através da proteína de fusão 
FKBP50::GFP e extractos proteicos da estirpe selvagem foi possível confirmar
a localização nuclear da FKBP50, a localização endoplasmática da FKBP22 e
a localização mitocondrial e citoplasmática da FKBP13. Foi também possível
determinar que a FKBP11 está localizada no citoplasma. Uma análise
bioquímica mais detalhada destas proteínas demonstrou que a FKBP11 não é 
expressa durante o desenvolvimento vegetativo do fungo mas a sua expressão
é induzida por elevados níveis de cálcio e durante o desenvolvimento sexual.
Através de imunoprecipitações usando um soro contra a FKBP13 foi possível
co-imunoprecipitar uma proteína de aproximadamente 40 kDa. O tratamento
de extractos proteícos mitocondriais e citoplasmáticos com diferentes
proteases demonstrou que a FKBP13 é extremamente resistente à proteólise 
por proteinase K e tripsina. A análise da expressão destas proteínas em 
resposta a diferentes indutores de stress sugere que a FKBP50 é regulada
negativamente pelo cálcio. Os níveis de FKBP22 encontram-se mais elevados 
em resposta ao stress osmótico e oxidativo e os níveis de FKBP13 encontram-
se também aumentados na presença de elevados níveis de FKBP11, 
sugerindo uma possível ligação entre FKBP13 e FKBP11. Embora a disrupção
dos genes fkbp11, fkbp13 e fkbp22 não conduza a num fenótipo detectável, a 
disrupção do gene fkbp50 resulta num fenótipo termo-sensível. No seu 
conjunto, os resultados este estudo demonstram que além do envolvimento no 
enovelamento proteíco, estas proteínas apresentam um conjunto de 
características particulares, provavelmente como resultado de funções
específicas. Com a caracterização das funções celulares realizadas por estas 
proteínas, esperamos descobrir um pouco mais sobre o papel das imunofilinas
em processos celulares fundamentais comuns a todos os eucariotas.  
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abstract 
 
Immunophilins are intracellular receptors of immunosuppresive drugs, as
cyclosporin, FK506 and rapamycin, found to possess peptidyl-prolyl cis-trans
isomerase activity. In addition to their involvement in protein folding, new data 
demonstrate the participation of these proteins in specific cellular processes as
signal transduction, protein trafficking and assembly and rDNA silencing. In this
study we proposed to characterize the cellular functions of the immunophilins of
the FKBP-type (FK506-binding proteins) identified in Neurospora crassa. In a 
search for the physiological role of these proteins we confirmed the cellular
location of proteins FKBP13, FKBP22 and FKBP50 and determined the
subcellular location of the FKBP11. We also analyzed the expression of these 
proteins in response to several stress inducers, performed
immunoprecipitations and produced and analyzed single and multiple mutants
for the fkbp genes. Using a GFP fusion protein and wild type protein extracts
we confirmed the nuclear location of FKBP50, the endoplasmic location of
FKBP22 and the mitochondrial and cytoplasmic location of FKBP13. We also
determine that FKBP11 is located in cytoplasm. A more detailed biochemical
analysis of these proteins revealed that FKBP11 is not expressed during 
vegetative development of the fungus but can be induced by high levels of
calcium and during sexual development. Through immunoprecipitation using an
antiserum against the FKBP13 we could coimmunoprecipitate a protein of
approximately 40 kDa. Treatment of wild type mitochondrial and cytoplasmic
protein extracts with different proteases showed that FKBP13 is highly resistant
to proteolysis by proteinase K and trypsin. Phenotypic analysis of the FKBPs 
expression in response to several stress inducers revealed that FKBP50 might
be down regulated by calcium. The FKBP22 levels were found to be specially
elevated in response to osmotic and oxidative stress and FKBP13 levels can 
be found notably high in the presence of high amounts of FKBP11, suggesting 
a possible relation between FKBP13 and FKBP11. Although disruption of the
fkbp11, fkbp13 and fkbp22 genes did not conducted to a detectable phenotype, 
disruption of the fkbp50 gene resulted in a temperature-sensitive phenotype. All
together the results of this work showed that besides the involvement in protein
folding these proteins present particular features, probably as a result of
specific cellular functions.  With the characterization of the cellular functions
mediated by these proteins we expect to find out a little more about the role of 
immunophilins in fundamental cellular processes common to all eukaryotes.  
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 Objectives 
 
In the last decades with the knowledge that PPIases, and in particular immunophilins, 
are involved in various and important cellular events, major advances have been made 
towards understanding the mechanism of action of these proteins in cell. Since 
immunophilins are extremely conserved among eukaryotes, the study of the cellular events 
mediated by these proteins became easier with the adoption of simple model organisms as 
fungi. In this study we proposed to characterize the cellular functions of the N. crassa 
FKBPs. Although the cellular location of FKBP13, FKBP22 and FKBP50 has been already 
established, the cellular location of FKBP11 remained to be determined. Through a 
biochemical analysis of these proteins and the production and characterization of fkbp 
mutant strains we expect to establish the cellular location of all the N. crassa FKBPs, the 
conditions where these proteins are (more) active, their mode of action and, if possible, 
their cellular partners. With this work we expect to discover a little more about the role of 
immunophilins in fundamental cellular processes common to all eukaryotes.  
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 Chapter 1. Introduction 
 
The success of organ transplantation depends mainly on the immunosuppressive 
therapy. The discovery and introduction in the 1980s of new and potent 
immunosuppressive drugs as FK506 (also known as tacrolimus), rapamycin (sirolimus) 
and cyclosporin A (CsA) have revolutionized allograft transplantation, leading to major 
advances in heart and liver transplantation. Currently, these drugs represent a powerful tool 
in the prevention of graft rejection after organ transplantation and treatment of autoimmune 
diseases (Oka and Yoshimura, 1996; Gummert et al., 1999; Allison, 2000). In a search for 
the molecular mechanism of action underneath immunosuppression, the intracellular 
receptors for these immunosuppressive drugs were found (Takahashi et al., 1989; Harding 
et al., 1989; Siekierka et al., 1989a; Siekierka et al., 1989b). Due to their immune 
properties, these intracellular receptors were named immunophilins. 
According to their affinity to different immunosuppressive drugs immunophilins can 
be classified in two families: the cyclophilins (CyPs), which bind CsA, and the FK506-
binding proteins (FKBPs), which bind the macrolides FK506 and rapamycin. CsA and 
FK506 mode of action is identical. Both drugs when complexed with the respective ligand 
inhibit the activity of calcineurin, a serine-threonine fosfatase that regulates IL-2 promoter 
induction after T cell activation, thereby suppressing the production of IL-2 and other 
cytokines. In contrast, rapamycin inhibits the activity of highly conserved kinases required 
for cell cycling and responses to IL-2 (Gummert et al., 1999; Cho et al., 2003; Allison, 
2000; Lee and Chapman, 2005). In addition to their immunosuppressive role, 
immunophilins are found to possess peptidyl-prolyl cis-trans isomerase (PPIase) activity.  
Along with the parvulin family, these proteins make part of the larger protein superfamily 
of peptidyl-prolyl cis-trans isomerases, as they are able to catalyse the cis-trans 
isomerization of the Xaa-Pro peptide bonds in oligopeptides and proteins, being thus 
involved in the acceleration of protein folding (Galat and Metcalfe, 1995; Göthel and 
Marahiel, 1999; He et al., 2004; Barik, 2006). In contrast to immunophilins, only a small 
number of parvulins or homologues are known. In opposite to the drugs CsA, FK506 and 
rapamycin which inhibit the enzymatic activity of immunophilins reversibly and 
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competitively, the enzymatic activity of several parvulins is irreversibly inhibited by jugole 
(Göthel and Marahiel, 1999).  
Recently, a new family of isomerases presenting both FKBP and CyP domains, 
named FK506 and cyclosporin-binding protein (FCBP), was found in the protozoan 
Toxoplasma gondi (Adams et al., 2005). In this parasite it was identified a protein of 57 
kDa containing simultaneously a N-terminal FKBP domain and a C-terminal CyP domain 
joined by three tetratricopeptide repeats (TPR). Both domains are functional and exhibit 
family-specific drug sensitivity. When expressed separately both domains present about 
half of the FCBP PPIase activity. Three new FCBP sequences were identified; two in 
Flavobacterium johnsonii and one in Treponema denticola. In these new sequences the 
domains are present in the reverse order, being the FKBP domain located in the C-terminal 
portion and the CyP domain in the N-terminal portion, constituting the main difference 
between FCBPs of eukaryotes and prokaryotes (Adams et al., 2005).  
Even though cyclophilins and FKBPs are non-related in primary sequence, both 
families present an extraordinary sequence conservation of the PPIase domains (Galat and 
Metcalfe, 1995). These ubiquitous and highly conserved proteins are found in all 
organisms, from archaea to man, and cellular compartments (Trandinh et al., 1992; Kay, 
1996; Galat, 2000; Vallon, 2005). Their wide distribution and functional conservation lead 
to a rising curiosity and interest in their potential cellular functions. In addition to a general 
role in accelerating protein folding, several studies show the involvement of PPIases in 
several and important cellular processes as signal transduction (Bram et al., 1993), protein 
trafficking (Stamnes et al., 1991, Chambraud et al., 2007), protein assembly (Wu et al., 
2004; Xiao et al., 2006), control of transcription (Arévalo-Rodríguez and Heitman, 2005), 
pre-mRNA splicing (Lorkovic et al., 2004), rDNA silencing (Kuzuhara and Horikoshi, 
2004), apoptosis (Baines et al., 2005) and cell-cycle regulation (Lu et al., 1996; Vittorioso 
et al., 1998). Characterization of the cellular functions of this group of proteins might 
provide us new insights of specific and complex cellular processes.  
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1.1 The role of immunophilins in immunosupression  
 
In mammals, the drugs FK506 and cyclosporin bind to different target molecules, 
although the mechanism of action of both drugs is identical. The process begins with the 
binding of the drug to its intracellular receptor, a FKBP or cyclophilin. It is known that the 
binding site of the drugs and the PPIase activity site are the same, since this activity is 
completely abolished when the complex drug-immunophilin is formed. However, 
immunosupression is not the result of PPIase activity inhibition. In fact, there is a gain of 
function, being immunossupression the result of a novel activity acquired by the complex 
formed that is not a property of the immunophilin or the drug alone (Galat and Metcalfe, 
1995; Gummert et al., 1999). The formation of the complex FK506-FKBP12/cyclosporine 
A-cyclophilin A inhibits the activity of calcineurin, a serine-threonine fosfatase that 
regulates IL-2 promoter induction after T cell activation (Figure 1). The inhibition of 
calcineurin blocks the calcium-dependent signal transduction and inhibits cytokine gene 
activation by inactivating the transcription factor NF-AT (nuclear factor of activated T 
cells). As a consequence, the transcription of cytokines IL-2, IL-3, IL-4, IL-5, interferon-γ, 
tumor necrosis factor-α, granulocyte-macrophage colony-stimulating factor, and IL-2 and 
IL-7 receptors is suppressed by FK506 and CsA. Other in vitro effects of FK506 include 
the inhibition of T cell proliferation, the inhibition of primary or secondary cytotoxic cell 
proliferation and the inhibition of B cell activation. In vivo, the FK506 inhibits 
proliferative and cytotoxic responses to alloantigens and suppresses primary antibody 
responses to T cell-dependent antigens (Gummert et al., 1999). 
Although the drugs FK506 and rapamycin share the same intracellular receptor, these 
two drugs inhibit the immune system through two different signal transduction pathways. 
Contrary to the FK506, the complex rapamycin-FKBP12 does not bind to calcineurin but 
to a highly conserved kinase named TOR (target for rapamycin) in yeast and plants and 
mTOR (or FRAP, FKBP and rapamycin associated protein) in mammals, essential for cell 
cycle progression. The formation of the complex rapamycin-FKBP causes the arrest of the 
cell cycle in the G1 phase. In view of that, the TOR protein is known to be a central 
regulator of cell growth and proliferation. The effects of the complex rapamycin-FKBP 
also comprise the inhibition of the IL-2 induced T cell proliferation, the B cell Ig synthesis 
and antibody-dependent cellular cytotoxicity, as well as inhibition of lymphocyte-activated 
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killer cells and natural killer cells (Gummert et al., 1999; Cho et al., 2003; Lee and 
Chapman, 2005).  
 
 
 
Figure 1. Mechanism of action of FK506 and cyclosporine A. The formation of FK506-
FKBP/cyclosporinA (CsA)-cyclophilin (CpN) complexes inhibit the activity of calcineurin 
(CaN), preventing the dephosphorylation of the nuclear factor of activated T cells (NF-
ATc) component and the transcription of the nuclear factor of activated T cells (NF-ATn), 
leading to the suppression of the transcription of several genes encoding cytokines.  
(http://journals.cambridge.org/fulltext_content/ERM/ERM2_04/S1462399400001769sup004.htm) 
 
 
1.2 Peptidyl prolyl cis-trans isomerase activity 
 
The proper folding of the primary sequence of the nascent polypeptide chain into a 
well-defined three-dimensional structure is critical in determining the protein physiological 
function in cell. During protein synthesis and folding, the torsion angle of a peptide bond 
can exist either in cis or in trans conformation, being the trans form energetically more 
favorable due to steric hindrance in cis. The unfavorable conformational energy of the cis 
peptide bond is the main reason of its relatively unusual appearance in the native structure 
of proteins. The only exception applies to the amino acid proline which has a much higher 
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probability to form a cis peptide bond with the preceding amino acid residue, due to the 
lower activation energy barrier of 13 kDa/mol for a Xaa-Pro bond against 20 kDa/mol for 
other peptide bonds (Galat and Metcalfe, 1995). Even though the cis-trans isomerization of 
peptidyl prolyl bonds has been identified as a spontaneous event, it occurs very slowly 
being frequently a rate limiting step in protein folding. In order to accelerate this process 
some enzymes became specialized in catalyzing the reversible cis-trans isomerization of 
the prolyl peptide bond, accelerating therefore protein folding and making it compatible 
with the rapid pace of other intracellular events (Figure 2). Several studies suggest that 
these proteins, also known as PPIases, may play a critical role in protein folding and 
assembly of multisubunit protein complexes. In some cases it is possible to demonstrate 
that the isomerization of proline bonds is the rate-limiting step in protein folding in vivo 
and in vitro (Kiefhaber et al., 1990; Steinmann et al., 1991; Kern et al., 1995). For 
instance, it has been found that SurA, a periplasmic protein in Escherichia coli similar to 
parvulin is involved in the folding of periplasmic and outer membrane proteins in vivo 
(Lazar and Kolter, 1996). It is believed that SurA maintains the outer membrane integrity 
since surA mutants became deformed and easily lysed during stationary phase. Other 
studies showed that the presence of CsA delays the collagen triple helix assembly in 
chicken embryo fibroblasts (Luan, 1998). Even though some PPIases present an active and 
crucial role in protein folding, in most of the cases it has been demonstrated that the PPIase 
activity is not essential for the organism survival. For example, the yeast Saccharomyces 
cerevisiae contains eight CyPs, four FKBPs and one parvulin. Disruption of all twelve 
immunophilins does not affect the dodecuplet mutant viability, showing that all the 
immunophilins are dispensable for the fungus survival (Dolinski et al., 1997). Although 
this function has been maintained extremely conserved during evolution, new data reveal 
that PPIases main function may not be the protein folding but rather perform specific 
functions through interactions with particular partner proteins.  
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Figure 2. Cis-trans isomerization of a peptidyl-prolyl bond. Adapted from Göthel and 
Marahiel, 1999. 
 
 
1.3 The FK506-binding proteins 
 
In 1989, two independent groups presented new outstanding results regarding the 
immunosuppression mechanism of action (Harding et al., 1989; Siekierka et al., 1989a; 
Siekierka et al., 1989b). Using a FK506 affinity matrix Harding and collaborators purified 
a protein of approximately 14 kDa from bovine thymus and human spleen (Harding et al., 
1989). This protein did not cross-reacted with antisera against cyclophilin and presented 
PPIase activity inhibited by FK506 (Figure 3). Although the similarity in the mechanism of 
immunosupression mediated by FK506 and CsA, the lack of sequence resemblance to 
cyclophilin lead to the establishment of a novel class of proteins with immune properties 
named FK506-binding proteins. Later the novel FK506-binding protein was characterized.  
The archetypal 12-kDa human FKBP isolated from bovine thymus and human spleen 
is at the present moment the well-characterized FKBP protein. This ubiquitously expressed 
cytosolic protein comprises 108 amino acids representing the minimal peptide sequence 
harboring PPIase activity and drug binding, serving as a model for the remaining members 
of the FKBP family. Ten amino acids define the hydrophobic core of the protein that forms 
the ligand-binding pocket. The hFKBP12 structure is constituted by five-stranded 
antiparallel β-sheet forming two loops. One of the loops includes a short section of an α-
helix. The β-sheet is twisted to give concave and convex surfaces with the concave surface 
made of hydrophobic residues that form the core of the protein and the hydrophilic 
residues projecting on the convex side making up much of the protein surface (Figure 4). 
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Although multiple alignment of FKBPs has shown some sequence divergence between the 
FKBP domains, the overall β-barrel/α-helix structure, the binding capacity to FK506 and 
rapamycin and the PPIase activity cleft remain conserved among different groups (Galat, 
2000; Breiman and Camus, 2002).  
 
 
A                                                                 B 
                   
 
Figure 3. Molecular structure of the drugs FK506 (A) and rapamycin (B). Both 
macrolides FK506, a polyketide produced by Streptomyces tsukubaesis, a specie initially 
discovered in Tsukuba, Japan, and rapamycin, isolated from S. hygroscopicus found on 
Easter Island, compete for the binding to the same intracellular receptor, a FKBP.  
 
 
As the cyclophilins, the FKBPs are ubiquitous proteins highly conserved during 
evolution, been found both in prokaryotes and eukaryotes. Using a specific nomenclature, 
these proteins are named using a prefix of one or two letters indicating species of origin 
and a suffix number indicating the molecular mass in kDa of the mature protein. Their 
classification into single or multiple domains is based on the number of FKBP domains. 
Usually small size FKBPs present only the FK506-binding domain, while high molecular 
weight proteins may present additional domains as TPR, WW domains, calmodulin-
binding sites, DNA and RNA-binding sites and dimerization modules, important for 
protein interactions (Breiman and Camus, 2002; He et al., 2004).  
 
 
Binding Domain Binding Domain 
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Figure 4. Human FKBP12 bounded to FK506. The FKBP12 represents the minimal 
sequence harboring the PPIase domain, whose activity is specifically inhibited by the 
macrolides FK506 and rapamycin. The human FKBP12 secondary structure is presented 
by different colors. (http://commons.wikimedia.org/wiki/Image:Fkbp-cartoon-1fkj.png) 
 
 
1.3.1 FKBPs and disease  
 
Since the involvement of FKBPs in several important cellular functions it is not 
surprising to found in recent literature new data describing the association of FKBPs and 
human diseases. In fact the absence or improper functioning of some of these proteins may 
be in the origin of quite a few severe human pathologies. The hFKBP12 is the best 
characterized member of the FKBP family. Several cellular functions are associated to 
hFKBP12. This protein was found to be tightly bound to the ryanodine receptor (RyR), a 
family of tetrameric intracellular calcium release channels required for excitation-
contraction coupling in striated muscle, forming a stable complex with a stoichiometry of 
one FKBP12 molecule per each RyR molecule regulating the channel activity (Lam et al., 
1995; Göthel and Marahiel, 1999; Breiman and Camus, 2002; Wang and Donahoe, 2004). 
Studies with mutant mice showed that the absence of FKBP12 altered the single-channel 
properties of both cardiac RyR2 and skeletal RyR1, leading to the development of severe 
cardiomyophaty and ventricular septal defects identical to human congenital heart 
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disorders. These results revealed to be very important in line to understand the cellular 
mechanisms of cardiac failure as well as to establish the FKBP12-deficient mice as a 
promising model for testing pharmacological agents and other therapies in the treatment of 
human heart diseases. Along with the hFKBP12, the mammalian FKBP52 is one of the 
best characterized FKBPs. Contrary to the hFKBP12, the mammalian FKBP52 does not 
present immunosuppressive activity when complexed with FK506. A single amino acid, 
Lys121, correspondent to Ile90 in hFKBP12, is the responsible for the lack of binding to 
calcineurin (Li et al., 2003; Davies and Sánchez, 2005). This lack of immunosuppressive 
activity is representative of the highly specialized nature of some of these proteins. Initially 
found as a member of an untransformed steroid receptor heterocomplexes (Wu et al., 
2004), it has been demonstrated that FKBP52 serves as a cochaperone for steroid hormone 
receptors when complexed with HSP90, promoting the proper translocation of estrogen, 
androgen and glucocorticoid receptors from the cytoplasm into the nucleus (Wu et al., 
2004; Davies and Sánchez, 2005). This function appears to be extremely important since 
male and female mice lacking FKBP52 display severe reproductive defects leading to 
infertility (Tranguch et al., 2005; Tranguch et al., 2006; Hong et al., 2007).  
New data show that immunophilins are more abundant in the nervous system than in 
immune tissues, suggesting neuroprotective and neurotrophic activities of these proteins. 
FKBP38, also known as FKBP8, is a transmembrane chaperone protein localized mainly in 
mitochocondria and endoplasmic reticulum that inhibits apoptosis by targeting two anti-
apoptotic proteins, Bcl-2 and Bcl-x, to mitochondria. A recent study showed that FKBP38 
is abundant in neurons and glial cells (Shirane et al., 2008). In this study, Shirane and 
collaborators created a FKBP38 nullizygous mice that soon during early stages of the 
embrionary development presented several neuronal defects as spina bifida, 
disorganization of the neuroepithelium and abnormal extension of the nerve fibers, dieing 
shortly after birth. Besides the neuronal defects, this mutant also display several skeletal 
defects as scoliosis, rib deformities, club foot and curled tail (Shirane et al., 2008). The 
development of neuronal defects appears to be related to an increase in frequency of 
apoptosis. Through a yeast two-hybrid system protrudin was identified as an interactor of 
FKBP38. Protrudin is a regulator of Rab11-mediate membrane trafficking being thus 
involved in neurite extension. In nullizygous mice, protrudin was found to be 
hyperphosphorilated suggesting that FKBP38 might regulate neurite outgrowth through 
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interaction with protrudin. All together these data indicate that FKBP38 regulates neurite 
extension and neuroectodermal organization during neural tube formation. As FKBP52, 
FKBP38 does not present immunosuppressive activity when complexed with FK506. 
FKBP38 lacks the conserved Trp59 in hFKBP12, important for the interaction with 
FK506, presenting instead a Leu residue at the correspondent position (Kang et al., 2008). 
In addition to the involvement in calcium regulation, it has been reported that the 
hFKBP12 might also have an active role in nerve regeneration. Its levels were found to be 
significantly altered in the brain of patients with neurodegenerative diseases such as 
Parkinson’s and Alzheimer’s diseases, dementia with Lewy bodies and in rats presenting 
crush injury of facial or sciatic nerves. It is proposed that hFKBP12 may degrade and 
prevent abnormal proteins aggregation by catalyzing protein folding, promote 
ubiquitination and transport of proteins through axons in a correct conformation during 
axon transport (Avramut and Achim, 2002).  
In contrast to neurotrophins, most immunophilin ligands are highly stable, being able 
to readily cross the blood barrier. The development of nonimmunosuppressive 
immunophilin ligands may represent a potent therapeutic alternative in order to reverse the 
neurodegenerative process and prevent apoptotic cell death in neurons (Kang et al., 2008).   
 
 
1.3.2 FKBPs in Yeast 
 
In the yeast S. cerevisiae genome four FKBPs were identified, Fpr1 to Fpr4. The 
yeast Fpr1 is the homolog of the mammalian FKBP12, presenting PPIase activity inhibited 
by FK506 and rapamycin. Deletion of the cytoplasmic Fpr1 leads to a slow growth 
phenotype, although fpr1 mutants also exhibit an increased resistance to LiCl and an 
enhanced recovery from α-pheromone induced cell cycle arrest when compared to the wild 
type strain (Dolinsky et al., 1997; Arévalo-Rodrígues et al., 2004). Several Fpr1 cellular 
partners have been identified. This protein appear to be necessary for the proper expression 
of the mammalian P-glycoprotein, an energy-dependent efflux pump that mediates tumor 
multidrug resistance by actively exporting various toxic molecules back out of the cell. In 
addition, Fpr1 is required for specific conformational changes in Hom3, an aspartokinase 
that catalysis an intermediate step in threonine and methionine biosynthesis, regulating 
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Hom3 feedback inhibition. Fpr1 was also identified as a cellular partner of Hmo1, a 
nucleolar-localized RNA polymerase I factor (Arévalo-Rodrígues et al., 2004).  
Fpr2 is a 13 kDa membrane associated protein localized in the ER. Fpr2 expression is 
induced by stress conditions, as heat shock or the presence of the antibiotic tunicamycin, 
and by the unfolded protein response (UPR) suggesting an active role of Fpr2 in protein 
transit in the ER under conditions that promote accumulation of unfolded proteins 
(Arévalo-Rodrígues et al., 2004).  
The Fpr3 and Fpr4 are nucleolar proteins. Both proteins associate with the ribosomal 
protein S24. Such complexes are not disrupted by FK506, suggesting that binding does not 
occur through the FKBP domain. Initially found in as the first phosphotyrosyl protein 
known to be a physiological substrate of Ptp1 (Wilson et al., 1995), the 70 kDa Fpr3 was 
also found to be a substrate for the yeast caseine kinase II protein Cka2. These two proteins 
regulate the phosphorylation level of Fpr3 residue Y184 in the N-terminal nucleolin-
related domain, affecting Fpr3 subcellular location (Arévalo-Rodríguez et al., 2004; 
Wilson et al., 1995). In addition, Fpr3 also prevent premature adaptation to persistent DNA 
damage, by inhibiting protein phosphatase 1 (PP1) activity (Hochwagen et al., 2005).  
In Schizosaccharomyces pombe it was identified a nuclear FKBP that associates with 
chromatin at rDNA loci, having an in vivo functional role in rDNA silencing, with a 
histone chaperone activity in vitro. Both activities are dependent of the N-terminal domain 
of the protein. Although, the C-terminal PPIase domain of the FKBP is not essential for the 
rDNA silencing and histone chaperone activities, it regulates rDNA silencing in vivo 
(Kuzuhara and Horikoshi, 2004). As the S. pombe nuclear FKBP, the S. cerevisiae Fpr4 
also displays a novel histone chaperone activity in vitro. This protein facilitates 
nucleosome assembly in a manner identical to other acidic histone chaperones, as NAP1, 
and acts as a chromatin component required for transcriptional silencing at the rDNA locus 
in vivo. Structurally the Fpr4 presents 3 well-defined domains, with an acidic domain at the 
N-terminus, a basic domain in the middle and a PPIase domain at the C-terminus. The Fpr4 
chaperone activity seems to be dependent on the acidic domain of the protein, even though 
the PPIase domain acts as an inhibitor of the histone chaperone activity, being this 
inhibition independent of the PPIase activity (Xiao et al., 2006).     
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1.4 Neurospora crassa 
 
Neurospora crassa is a bright orange filamentous fungus belonging to the 
Ascomycete division. The Neurospora genus can be found in all moist tropical and 
subtropical areas and in temperate areas near of agriculture areas. First documented in 
1843 as a contaminant of bakeries in Paris, soon Neurospora was identified as a prolific 
contaminant of sugar cane processing plants and burned vegetation, mainly due to the 
requirement of heat shock activation (Davies and Perkins, 2002; Galant et al., 2003). 
Although in past this conspicuous fungus had been known for approximately eighty four 
years, only in 1927 Cornelius L. Shear and Bernard O. Dodge presented for the first time 
the Neurospora crassa species description and classification (Horowitz, 1991). Even 
though Dodge’s genetic work on Neurospora had contributed notably to the establishment 
of Neurospora as a model organism, only in 1941 with Edward L. Tatum and George W. 
Beadle landmark paper, N. crassa was accepted by the scientific community as a model 
organism. In this work, Tatum and Beadle exposed N. crassa to a series of random 
mutations caused by x-rays. The results of this study revealed the existence of flaws in 
some metabolic pathways caused by the mutation of specific enzymes, leading to the “one 
gene – one enzyme” theory, proving that genes control the fundamental processes of life. 
With this brilliant result, Tatum and Beadle won the Nobel Prize in physiology or medicine 
in 1958 (Horowitz, 1991; Davis, 2000).  
Currently with the high number of model organisms documented, N. crassa is still 
accepted as an excellent model organism in what concerns the study of diverse aspects of 
eukaryotic cell biology. Although presenting the same basic biochemistry and cell biology 
of Saccharomyces, the more complex development with distinct, differentiated cell types 
and the genetic mechanisms more close to other eukaryotes make of this filamentous 
fungus one of the best contributors for the finding and characterization of different cellular 
mechanisms (Perkins and Davis, 2000). 
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1.4.1 N. crassa life cycle         
 
In nature, N. crassa usually reproduces asexually with the production of bright 
asexual spores named conidia. In normal conditions, conidia germinate forming an initial 
germ tube that extends to form hyphae, which continues to grow by tip extension and 
branching to form a mycelium (Figure 5). The N. crassa mycelium presents multinucleated 
cells separated by perforated cross-walls allowing the flow of cytoplasm, nuclei and other 
organelles. In situations of nutrient exhaustion, the mycelium can produce two types of 
asexual spores named macro and microconidia. The macroconidia are formed by budding 
and constriction of aerial hyphae presenting one to several haploid nuclei, being the 
macroconidia with two nuclei the most frequent. In contrast, microconidia are extruded 
directly and serially from cells of small branched microconidiophores (Davis, 2000).  
In situations of stress imposed by low luminosity, low temperature or low nitrogen 
sources the N. crassa sexual cycle is initiated. N. crassa is a heterotallic specie, meaning 
that sexual cycle requires the presence of two genetically different parents, known as 
mating types A and a. The mating types are determined by alternate DNA sequences at a 
chromosomal locus (locus mating type). Mating can only occur between different mating-
types.  
The female reproductive structure is a protoperithecium and the male fertilizing agent 
is normally a conidium or hyphae of the opposite mating-type. Protoperithecia are formed 
as a small knot of hyphae that surrounds some special cells, one of which acting as the 
female gamete (ascogonium). The outer hyphae of the protoperithecium form a dense 
protective layer through which emerges one or more specialized hyphae named 
trichogynes. Trichogynes respond to a pheromone emitted by conidia of the opposite 
mating-type by growing toward them until contact and cell fusion occurs. Upon fusion, a 
nucleus of the conidium travels through the tricogyne to the ascogonium in the 
protoperithecium. In the protoperithecium, the nuclei of both mating-type do not fuse but 
proliferate through a succession of divisions developing a mass of ascogenous hyphae. In 
the subapical cell of the crozier, a binucleate hook-shaped structure, pre-meiotic DNA 
replication takes place prior to nuclear fusion. Nuclear fusion completes the fertilizing 
process, yielding the only diploid stage of the life cycle. The diploid nucleus immediately 
undergoes a meiotic division. Each of the four meiotic products originated undergoes one 
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mitotic division resulting in the production of eight nuclei. If the parents have different 
alleles at one gene, asci will contain four nuclei of one parental type and four nuclei of the 
other. Therefore, the mating-type alleles will emerge as 4 mat A:4 mat a spore cultures. As 
asci form, perithecia enlarge and the walls became hard and melanized. A beaklike 
structure forms at the top of the perithecium containing a pore named ostiole, through 
which ascospores are forcibly ejected in groups of eight, each comprising the contents of 
an ascus. When ascospores are fully mature they germinate upon heat activation, being this 
one of the reasons why Neurospora is found in areas of burned-over vegetation (Davis, 
2000). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. N. crassa life cycle. N. crassa presents a heterothallic life cycle where mating 
can only occur between different mating-types (A and a), leading to the development of 
specialized structures.  
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1.4.2 N. crassa as a model organism         
 
The broad biological knowledge of Neurospora, from the molecular to the population 
level, makes it one of the best model organisms in the study of numerous cellular 
processes. At the cellular level, N. crassa simple life cycle, fast growth, ease of culture and 
simplicity in what concerns to nutritional requirements makes it a fungus easy to maintain 
and cultivate in laboratory. N. crassa is also a haploid fungus easy to manipulate 
genetically. This fungus presents Mendelian segregation, being the recognition of recessive 
loss-of-function mutations usually straightforward. This feature can be extremely useful in 
the study of mutant strains for particular genes. In addition N. crassa presents one of the 
most intriguing processes occurring in nature. Through a natural phenomenon named 
repeat-induced point mutations (RIP) it is possible to obtain mutant strains. In this process 
when a plasmid containing a copy of a specific gene is integrated in the Neurospora 
genome and the transformant obtained crossed with a wild type strain of the opposite 
mating-type, inactivation of both copies of the gene can occur during sexual development 
through a series of mutations involving GC to AT base pair transitions followed by DNA 
mutilation (Videira, 2001). This interesting process is known as a defense mechanism 
against selfish and mobile DNA, preventing gene innovation through gene duplication and 
it is extensively used to produce N. crassa mutant strains for specific genes (Cambareri et 
al., 1991, Davis, 2000; Galant et al., 2003).              
In the Nature edition of 24th April of 2003, the N. crassa genome was reported as 
fully sequenced (Galant et al., 2003). The N. crassa genome presents 43 megabase and 
encodes around 10.000 genes distributed by 7 chromosomes. Being the first filamentous 
fungus having its genome fully sequenced and available freely has contributed 
significantly to a better understanding of a great number of cellular processes as cellular 
signaling, growth and differentiation, metabolic activities and genome defense (Horowitz, 
1991; Perkins and Davis, 2000; Davis and Perkins, 2002; Galant et al., 2003).  
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1.4.3 N. crassa FKBPs 
 
Four immunophilins belonging to the FKBP family, named FKBP11, FKBP13, 
FKBP22 and FKBP50 were identified in the last genome annotation of N. crassa (Table 1) 
(Neurospora sequencing project, Whitehead Institute/MIT Center for Genome Research). 
The accession numbers for the FKBP11, FKBP13, FKBP22 and FKBP50 proteins are 
NCU04371.3, NCU04140.3, NCU02455.3 and NCU03241.3, respectively. 
The FKBP22 protein is encoded by the fkr-5 gene, located in linkage group VII, and 
is constituted of 217 amino acids, with a N-terminal presequence of 20 amino acids. The 
mature FKBP22 presents 197 amino acids with a N-terminal PPIase domain and a C-
terminal domain, with no homologies to other proteins, with an ER retention signal 
(HNEL) (Tropschug et al., 1990). The cellular functions of FKBP22 have been recently 
characterized (Solscheid and Tropschug, 2000; Tremmel et al., 2007; Tremmel and 
Tropschug, 2007). FKBP22 is a homodimeric protein located in the lumen of the ER with a 
novel chaperone activity. This protein interacts directly with BiP, the major HSP70 
chaperone in the ER, through its FKBP domain, being BiP able to enhance FKBP22 
chaperone activity. BiP and FKBP22 form a stable folding helper complex with a high 
chaperoning activity preventing the aggregation of unfolded rhodanese (Tremmel and 
Tropschug, 2007). FKBP22 appears also to form other chaperone/folding catalyst 
complexes with disulfide isomerases, like ERp38 and PDI, Grp170, another ER HSP70 
chaperone, and Cyp23, a cyclophilin, being the organization of such complexes mediated 
by BiP. FKBP22 is as well involved in the development of microconidiophores (Tremmel 
et al., 2007).  
The fkr-2 gene, located in linkage group V, encodes FKBP13, a protein of 176 amino 
acids with a putative N-terminal mitochondrial presequence. The FKBP13 presents only a 
PPIase domain (Figure 6). FKBP13 was originally isolated from a cytosolic fraction 
(Tropschug et al., 1990). Later it was found that an identical protein can be identified in 
the mitochondrial matrix, indicating that FKBP13 has a dual location in N. crassa. Both 
proteins are the product of the single nuclear gene fkr-2. The mitochondrial protein is 
synthesized as a precursor with a long presequence of 56 amino acids, which is cleaved in 
two steps upon entry into the mitochondrial matrix (Tropschug, 1997). Mutants in fkr-2 
gene lead to the loss of FKBP13 both in the cytosol and mitochondria. These mutants are 
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FK506 resistant, proving that FKBP13 is the major receptor for FK506 in N. crassa 
(Barthelmess and Tropschug, 1993).  
The fkbp11 gene (fkr-3) is located in linkage group IV and it is composed by five 
exons and four large introns. This gene codes for a protein of 113 amino acids with no 
retention signal characterized, presenting only a PPIase domain (Figure 6). The gene 
fkbp50 localized in linkage group I is composed by four exons and codes for a protein of 
467 amino acids with a predicted mass of 50774.2 Da. The FKBP50 displays a conserved 
C-terminal PPIase domain, an N-terminal acidic domain and a basic domain in the middle 
(Figure 6). Previous work using a FKBP50::GFP fusion protein suggests that it is localized 
in the nucleus (Duarte et al., 2004).   
 
 
 Protein Gene Chromosome Exons MW (kDa) 
FKBP11 fkr-3 IV 5 11.18 
FKBP13 fkr-2 V 2  19.24* 
FKBP22 fkr-5 VII 2 23.04 
FKBP50 fkr-4 I 4 50.77 
 
 
 
 
 
 
Table 1. Main characteristics of the fkbp genes. The molecular weight of FKBP22 has 
been published previously; the predicted molecular weight of the remaining proteins was 
calculated using the Molecular Weight Calculator program from EnCor Biotechnology. 
*Molecular weight of the mature cytosolic FKBP13. 
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Figure 6. Schematic representation of the structures of N. crassa FKBPs. The numbers 
indicate the amino acid positions. The scan for multiple domains was performed using the 
ScanProsite program. FKBP13 and FKBP22 targeting sequences to mitochondria 
(Tropschug, 1997) and ER (Tropschug et al., 1990), respectively, are shown in black. 
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 Chapter 2. Materials and Methods 
 
2.1 N. crassa strains  
 
The fungal FGSC#6103 strain, a kind gift from Dr Michael Freitag (University of 
Oregon, USA), was maintained on Vogel's minimal medium (VMM) supplemented with 
200μg/ml L-histidine-HCl. The strains ∆fkbp11 (FGSC#15831A), ∆fkbp13 
(FGSC#11562A and FGSC#11563a) and ∆fkbp50 (FGSC#12177a) were obtained from the 
Fungal Genetic Stock Center (FGSC), Neurospora Genome Project – Dartmouth and were 
maintained in VMM containing 100μg/ml hygromycin B. The mutants fkbp22RIP 
(Tremmel et al., 2007) and fkbp50RIP were obtained by RIP. 
 
 
2.2 Media and culture conditions 
 
N. crassa strains were maintained in slants containing solid VMM supplemented with 
1,5% sucrose and the required supplements, according to standard procedures (Davis and 
de Serres, 1970). For vegetative growth, strains were cultured either in liquid or solid 
VMM containing different substrates. Crosses between single, double and triple mutants 
were performed on solid Westergaard's medium (Westergaard and Mitchell, 1947). For 
protein isolation of cultures subjected to different stress conditions, conidia were 
inoculated in liquid VMM at a final concentration of 109cells/L and the cultures grown at 
26 and 30ºC with agitation for approximately 16h. After that time the different stress 
inducers were added and the cultures left to grow for approximately 4h and 30min. For 
mating conditions, strains were inoculated in solid Westergaard’s medium at a final 
concentration of 109cells/L and incubated without agitation at 26ºC for several days.  
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2.3 Cloning experiments 
 
In order to determine the subcellular location of the FKBP11 protein, we induced its 
expression using a plasmid commonly used to obtain green fluorescent protein (GFP) 
fusions. For that purpose the fkbp11 gene was amplified from the genomic DNA, using the 
the primers 11fwd: 5’-GGATCCAATGGGTGTCAACAAAATCACTC-3’, 11rev: 5’-
GGATCCCAGTGAACCGCCCAGCTACTG-3’, and cloned into pCRII-TOPO vector 
(Invitrogen). The construct was transformed in E. coli DH5α strain and its sequence 
confrmed by DNA sequencing. The recombinant plasmid pTOPO.gene11 was digested 
with BamHI and the gene fragment cloned into the pMF272 plasmid (FGSC). Spheroplasts 
of the N. crassa FGSC#6103 strain were transformed with the recombinant vector. 
Genomic DNA from several transformants was analysed by Southern blotting to identify 
strains with single-copy integration. One was referred as OEFKBP11 and used for further 
analysis. 
 
 
Pre-
denaturation 1
st Cycle 2nd Cycle 3rd Cycle  
 30'' 95ºC  30'' 95ºC  30'' 95ºC  5' 72ºC 
1' 95ºC (1x) 30'' 43ºC (10x) 30'' 48ºC (10x) 30'' 53ºC (10x) 4ºC ∞ 
 1' 72ºC  1' 72ºC  1' 72ºC   
 
Table 2. PCR amplification protocol used to amplify the gene fkbp11. 
 
 
2.4 Construction and expression of NcFKBP50::GFP fusion protein 
 
To analyse the subcellular location of the FKBP50 protein we used strain expressing 
a green fluorescent protein (GFP) fused to the C-terminus of the protein previously 
available in the laboratory. The fkbp50 cDNA lacking the stop codon was amplified by 
PCR using the primers F50fwd: 5’-GGATCCATGCCTGTCGCCGTTTTTGGC-3’ and 
F50rev: 5’-GGATCCACTTGATCTCAAGGAGCTTGACG-3’. The amplified 1.4kb 
fragment was cloned into pGEMT-easy vector (Promega) and the resulting plasmid 
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digested with BamHI to excise the fkbp50 cDNA band, which was then cloned in frame 
with the GFP gene in pMF272 (FGSC). This expression vector was transformed into the N. 
crassa FGSC#6103 strain and a single-copy transformant stably expressing the FKBP50 
protein fused to GFP was selected (Duarte et al., 2004). Live cells were stained with 0,5 
μM DRAQ5 (Biostatus) for visualization of nuclei and cell images were collected in a 
Leica Confocal SP2 using filter sets optimal for GFP and DRAQ5 red fluorescence (Leica 
Microsystems).  
 
 
2.5 Southern blot  
 
In order to identify the N. crassa fkbp11 mutants and fkbp11 overexpressing strains, 
different strains were grown overnight in liquid VMM. As positive control the N. crassa 
74A strain was included. Genomic DNA was isolated as previously described (Yarden et 
al., 1992). The genomic DNA of different strains was digested with BamHI 
electrophoresed in 0,9% agarose gels (Sambrook and Russell, 2001). The gels containing 
the separated DNAs were washed once with water and a denaturing solution (1,5M NaCl, 
0,5M NaOH) during 20 min at room temperature (RT) with agitation. After a new wash 
with water, the gels were washed with a neutralizing solution (1,5M NaCl, 1mM EDTA, 
0,5M Tris /HCL pH 7,2) for 15 min at RT with agitation. The neutralizing step was 
repeated once again. After neutralization, the gels were transferred to nylon N+ membranes 
(GE Healthcare) using a vacuum blotter. During transference the gels were systematically 
covered with 20xSSC (3M NaCl, 0,3M sodium citrate pH 7,0) to avoid dryness. The blots 
were pre-hybridized with a solution constituted by 5xSSC (0,75M NaCl, 75mM sodium 
citrate pH 7,0), 1:20 blocking agent (GE Healthcare), 0,1% sodium dodecyl sulfate (SDS) 
and 5% dextran sulphate, for 30 min at 65ºC with agitation. As probe it was used the 
fkbp11 gene extrated from the pTOPO.gene11 plasmid digested with BamHI. The fkbp11 
gene labelling was performed using the Gene ImagesTM Random Prime Labelling Module 
kit (GE Healthcare). The labelled DNA was added to the pre-hybridization solution and the 
blots incubated with this solution overnight at 65ºC with agitation. After hybridization, the 
blots were three times washed at 65ºC with 1xSSC plus 0,1% SDS; 0,5xSSC plus 0,1% 
SDS and 0,1xSSC plus 0,1% SDS. After the washes, the blots were washed with buffer A 
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(150mM NaCl, 100mM Tris/HCl pH 9,5) and buffer A plus 1:10 blocking agent for 1h at 
RT with gentile agitation. The blots were washed again with buffer A and incubated with a 
solution containing buffer A, 0,5% BSA and 1:5000 alkaline phosphatase (AP) conjugated 
with anti-fluorescein during 1h at RT with gentile agitation. After three 10-min washes 
with buffer A plus 0,3% Tween 20, the blocking agent was added and the blots exposed to 
a x-ray film (Kodak BioMax Light Film) during 45 min.     
 
 
2.6 Organelle isolation 
 
The wild type and OEFKBP11 nuclei isolation was performed using some protocol 
modifications to the procedure already described (Hautala et al., 1977). Conidia from 7-
day agar cultures were inoculated to a final concentration of 109cells/L into 1 liter of VMM 
and incubated with agitation at 26ºC overnight. The mycelia was collected and 
mechanically broken in a grinder in ice-cold buffer A (1M sorbitol, 7% Ficoll 400, 20% 
glycerol, 5mM MgCl2, 10mM CaCl2, 0,5% Triton X-100) and the homogenate centrifuged 
at 500 x g for 10 min at 4ºC. The supernatant was immediately and carefully removed 
avoiding the inclusion of any loosely packed pellet and a volume of buffer A equal to the 
volume of the supernatant removed was added to the centrifuge bottle. The suspended 
pellet was homogenized and centrifuged as described above. The supernatant was also 
collected and this procedure repeated a second time. The three supernatants were combined 
and centrifuged at 9,000 x g for 40 min to yield a crude nuclear pellet. The crude nuclear 
pellet was suspended in buffer B (1M sucrose, 50mM Tris pH 7,5, 5mM MgCl2, 10mM 
CaCl2, 1% Triton X-100) and homogenized in a Potter-Elvehjem tissue grinder. The 
nuclear suspension was layered onto a 50, 25, 12,5% sucrose gradient and the gradient 
centrifuged for 25 min at 8,500 rpm in a Sorvall RC5C centrifuge. After centrifugation, the 
nuclei were visible as a discrete white band between the 25 and 50% sucrose layers. The 
nuclei layer was removed using a syringe and diluted in buffer B. In order to obtain a pure 
nuclear pellet, the suspension was centrifuged at 5,000 x g for 20 min and the pellet 
suspended in a minimal volume of buffer B. The nuclei were stored at –80 º C.   
The wild type and OEFKBP11 isolation of mitochondria, endoplasmic reticulum and 
cytoplasm were also performed using some protocol modifications to the methods already 
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described (Borgeson and Bowman, 1983). As described for nuclei isolation, conidia from 
7-day agar cultures were inoculated to a final concentration of 109cells/L into 1 liter of 
VMM and incubated with agitation overnight at 26ºC. The mycelia was collected and 
mechanically broken in a grinder in MIM buffer (0,44M sucrose, 2mM EDTA, 30mM 
Tris/HCl pH 7,6). The homogenate was centrifuged for 5 min at 3,500 rpm at 4ºC in a 
Sorvall RC5C centrifuge. The supernatant obtained was transferred into a new centrifuge 
bottle and the centrifugation repeated as above. To obtain the full-extract fraction, 10 ml of 
supernatant was collected and added 1% Triton X-100. The remaining supernatant was 
centrifuged again for 50 min at 10,500 rpm at 4ºC. The supernatant obtained was saved for 
ER isolation and the pellet suspended in MIM buffer and centrifuged for 20 min at 16,500 
rpm at 4ºC. The resulting pellet was subjected to a 30, 40, 50, 60% sucrose gradient and 
centrifuged for 20 min at 8,500 rpm at 4ºC. The mitochondria layer was collected, 
suspended in MIM buffer and centrifuged for 20 min at 16,500 rpm. The resulting 
mitochondria pellet was suspended in MIM buffer. The supernatant saved for ER isolation, 
was centrifuged for 1h at 100,000 x g in an Ultra Sorvall centrifuge at 4ºC. The resulting 
pellet corresponding to the ER was suspended in a minor volume of MIM buffer and the 
supernatant saved as the cytoplasm fraction.  
 
 
2.7 Western blot  
 
The cellular fractions corresponding to full-extracts, nuclei, mitochondria, ER and 
cytoplasm were separated on SDS-polyacrylamide gels and transferred to nitrocellulose 
Hybond C extra membranes (GE Healthcare) by electroblotting using a semi-dry blotter. 
After staining with PounceuS, the blots were washed with TBS buffer (150mM NaCl, 
10mM Tris/HCl pH 7,5) and blocked with 5% milk in TBS for 1h at RT. After a wash with 
TBS, the blots were incubated with the respective antibodies diluted in TBS with 0,1% 
bovine serum albumin (BSA) at 4ºC overnight. The sera and dilutions used were: AS-
FKBP11 (1:250), AS-FKBP13 (1:1000), AS-FKBP22 (1:1000), AS-FKBP50 (1:1000), 
AS-CIII (1:1000) and AS-COREII (1:1000). Blots were washed three times for 10 min 
with TBST (TBS with 0,05% Triton X-100) and incubated with a anti-rabbit goat 
immunoglobulin  conjugated with AP (Sigma) diluted 1:7500 in TBS with 5 % milk  for 1h 
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at RT. After three 10-min washes with TBST, the blots signal detection was performed 
using 1:1000 Nitro blue tetrazolium (NBT, 75mg/ml) and 1:1000 5-Bromo-4-chloro-3-
indolyl phosphate (BCIP, 50mg/ml) in AP buffer (100mM NaCl, 5mM MgCl2, 100mM 
Tris/HCl pH 9,5).    
 
 
2.8 Proteases accessibility 
 
Approximately 100µg of mitochondrial and cytoplasmic protein extracts were 
prepared in SEM buffer (0,25M sucrose, 2mM EDTA, 10mM MOPS/KOH pH 7,2) were 
solubilized with 1% Triton X-100 or 0,5% SDS in a final volume of 100µl (complete final 
volume with SEM buffer). The samples were incubated 3 min on ice. Each sample was 
diluted in fifteen times the volume in SEM K buffer (SEM buffer with 80mM KCl). To 
each sample 30 or 45µg/ml of proteinase K or trypsin was added and the samples 
incubated for 20 min on ice. Next, 2mM of the protease inhibitor phenylmethylsulphonyl 
fluoride (PMSF) was added and the samples incubated 5 min on ice. The samples were 
centrifuged 5 min at 14,000 rpm. The pellet was washed with acetone and centrifuged 
again 5 min at 14,000 rpm. The pellet was suspended in 30µl of 1x GLB. The entire 
sample was loaded in a 17,5% SDS-PAGE gel. The gel was transferred into a 
nitrocellulose Hybond C extra membrane (GE Healthcare) using a semi-dry blotter. The 
membrane was incubated with antisera against FKBP13, FKBP22 and a mitochondrial 
complex III protein (CIII) overnight as described above.  
 
 
2.9 Immunoprecipitation experiments 
 
Approximately 1,5mg of N. crassa wild type and ∆fkbp13 total extracts and 
mitochondrial proteins were solubilized in a buffer containing 300mM NaCl, 30mM Tris 
pH 7,5, 0,5mM PMSF and 0,5% Triton X-100 or 0,5% digitonin (DIG) or 0,5% n-dodecyl-
β-D-maltoside (DDM). The samples were incubated on ice for 15 min, with vortexing mix 
every 3 min, and centrifuged at 13,500 rpm for 25 min at 4ºC. The supernatants were 
collected and 30μl of serum against the N. crassa FKBP13 were added to each sample. The 
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samples were incubated in an orbital mixer overnight at 4ºC. After incubation, 150μl of 
62,5mg/ml Protein A immobilized on Sepharose (Sigma) in 30mM Tris pH 7,5 was added 
to each sample. The mixtures were incubated for 2 hours in the orbital mixer at 4ºC. After 
centrifugation at 13,500 rpm for 1 min at RT, the pellets obtained were six times 30-sec 
washed with 300mM NaCl, 30mM Tris pH 7,5 and 0,4% Triton X-100 and four times 30-
sec washed with 30mM Tris pH 7,5. The final sediments were suspended in 100μl 1x gel 
loading buffer (2% SDS, 0,1% bromophenol blue, 10% glycerol, 50mM Tris/HCl pH 6,8). 
The samples were mixed for 1 hour and heated for 10 min at 65ºC. After a 10 min 
centrifugation the supernatants were collected. Approximately 200μg of each sample were 
separated on a 17,5% SDS-PAGE gel and the resulting gel stained with Coomassie 
Brilliant Blue.  
 
 
2.10 Silver staining  
 
The gel stained with Coomassie Brilliant Blue was washed 5 min with distillated 
water and fixed for 3h in a solution containing 2% ethanol and 5% acetic acid (v/v). After a 
new 5 min wash with distillated water, the gel was fixed again for 30 min in a 10% 
glutaraldehyde (v/v) solution. After fixation, the gel was five times 30-min washed with 
distillated water to remove glutaraldehyde excess and incubated for 10 min in a freshly 
made ammoniacal silver nitrate solution (per 750ml of solution: 10ml concentrated 
NH4OH, 1,5ml 10M NaOH, 30 ml 1,2M AgNO3). The gel was washed three times for 5 
min with distillated water and the image developed with a solution containing 1% citric 
acid and 0,037% formaldeid. The reaction was stopped 3 min latter using a 5% acetic acid 
(v/v) solution.  
 
 
2.11 Phenotypic analysis 
 
i) Linear growth tests. The growth rates of several N. crassa strains were tested on 
VMM medium containing different substrates at 26 and 37ºC using race tubes. ii) Fertility 
tests. To analyze the role of the fkbp11 gene in sexual development, both fkbp11 mutants 
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(mating-types A and a) were crossed to the wild type as either the female or male parent to 
detect dominant-specific defects. When used as male, a small drop of conidial suspension 
was spotted onto wild type (A and a) strains grown on plates with Westergaard’s crossing 
medium. When used as females, the mutants were grown in plates containing the same 
crossing medium and fertilized three days later with wild type conidia from the opposite 
mating-type.      
 
 
2.12 Miscellaneous  
 
The techniques used for PCR and general cloning (Sambrook and Russell, 2001), 
protein determination (Bradford, 1976), SDS-polyacrylamide gel electrophoresis (Zauner 
et al., 1985) and digestion of mitochondria with digitonin (Carneiro et al., 2007) have been 
published before.  
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 Chapter 3. Results and Discussion  
 
3.1 Cloning and production of OEFKBP11 
 
Further work showed that FKBP11 is not expressed during vegetative development 
of N. crassa. In order to determine the cellular location of this protein we constructed a 
strain overexpressing FKBP11. Based on the gene sequence of the fkbp11 gene available at 
the Broad Institute (http://www.broad.mit.edu/annotation/genome/neurospora) we designed 
primers and amplified the respective gene by PCR. The sequencing results were aligned 
with the respective genomic sequence using the Blast program. The sequencing results 
related to the fkbp11 gene showed no differences to the sequence previously annotated, 
although we have previously verified through fkbp11 cDNA amplification and sequencing 
that three codons initially annotated as the final part of the first intron of the fkbp11 gene 
are in fact the beginning of the second exon (Figure 7). Two of the codons code for the 
amino acids glutamate and phenylalanine (this sequence provides a recognition site for the 
restriction enzyme EcoRI) and the third codon encodes the amino acid serine (Pinto, 2006).  
The fkbp11 gene amplified by PCR was cloned in BamHI site of the plasmid pMF272 and 
the construct obtained used to transform N. crassa.  The gene was integrated in the his-3 
locus of a N. crassa his-3 auxotrophic mutant strain (FGSC#6103) by homologous 
recombination. Transformants were selected on a histidine-free Vogel’s minimal medium 
with sorbose to induce colonial growth. Resulting prototrophic His+ transformants were 
isolated and analyzed by Southern blotting to identify the correct genotype. The fkbp11 
gene extracted from the pTOPO.gene11 construct was used as probe in the Southern 
blotting analysis. In Figure 8A, we can see that both transformants selected (T1 and T2) 
present an extra copy of the fkbp11 gene, in contrast to the wild type strain that only 
contains the endogenous fkbp11. Wild type, T1 and T2 protein full-extracts were also 
analysed by Western blotting using an antiserum against the FKBP11 to confirm that both 
strains were expressing the FKBP11 (Figure 8B). Since there were no significant 
differences in the FKBP11 expression between both transformants, T1 was selected to 
further experiments.   
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1  atgggtgtcaacaaaatcactcacgttgcgggtaccgggccacaaccagaagctggc
1   M  G  V  N  K  I  T  H  V  A  G  T  G  P  Q  P  E  A  G   
58  cagaccgtggttatcgagtatactggttggctgaaggactcgagccaggccgatgga
20   Q  T  V  V I  E  Y  T  G  W  L  K  D  S  S Q  A  D  G   
115  aagggagccgagtatgttcttttccccattgaaaaatcttgccttaccacacacgtc
39   K  G  A  E                                                
172  tccggttgttggtcagttttgataacactatatccagattcgacagctcgatcggtc
43 F  D  S  S I  G    
229  gtggggattttgtcacgcaaatcggggttgggagactcatcagaggtatatgcccac
49  R  G  D  F  V  T  Q  I  G  V  G  R  L  I  R                
286  catcggtccacttttttcatatatcggagactttatgctgacgtgctgcttttgtga
343  cgggcataggatgggatgaggctgtattgaaaatgaaggttggcgagaaagccactt
64           G  W D  E  A  V  L  K  M  K  V  G  E  K  A  T     
400  tggatatttctaggtgagttattcgtgagtgaacgatgtgtcaggggaagaaattga
80  L  D  I  S  S
457  tactgacgagacaatatgttttagtgattacggatacggagagcggtgagtaacctg
85                            D  Y  G  Y  G  E  R              
514  caggccttttttttttctttcttctgaaaatccaaaaaaatcagtctatatggtgta
571  acaccacccgcagacacgatacttctggccgtgctgatttggagttaatgcccatgt
628  gctgacccgacttattgcacaccaggggttttcacggccacattcctccgaacgcag
92                             G  F  H  G H  I  P  P N  A     
685  atttgatcttgtgagttgtctcctgtatgccacatatcttgctccagcttgtctcta
102  D  L  I  F                                                 
742  cagtcaaggtagcggcgggcaagatagcgtcagcaaggatacgagctaatatgtgat
799  agtgacgtatatctcaagggtctccagtag
106      D  V  Y  L  K  G  L  Q  *                              
 
  
 
Figure 7. Nucleotide and deduced amino acid sequence of the FKBP11. Exons and 
introns are in capital and lower case letters, respectively. The codons initially identified as 
being part of the first intron sequence but that in fact are the beginning of the second exon 
sequence are in bold (Pinto, 2006). 
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Figure 8. Identification of strains overexpressing FKBP11. A. Identification of N. 
crassa strains containing an extra copy of the fkbp11 gene by Southern blotting using as 
probe the fkbp11 gene extracted from the pTOPO.gene11 plasmid digested with BamHI. B. 
Protein full-extracts of the same strains were analyzed by Western blotting to confirm that 
both transformants express the FKBP11. WT - wild type; T1 - transformant 1; T2 - 
transformant 2.  
 
 
3.2 Cellular location of FKBPs 
 
In this work we have confirmed the FKBP13, FKBP22 and FKBP50 cellular 
locations and determined the subcellular location of the protein FKBP11. To confirm the 
subcellular location of FKBP50, we used a strain expressing a green fluorescent protein 
(GFP) fusion, previously produced in the laboratory, and performed colocalization studies 
with different dyes specific for different organelles. To obtain this strain, the cDNA 
encoding FKBP50 was cloned in frame with the GFP gene, under the control of an 
  WT  T1  T2bp
23.130
9.416
6.557
4.361
Endogenous 
fkbp11
2.322
2.027
Exogenous 
fkbp11
564
B FKBP11
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inducible promoter. The fusion construct was targeted to the his-3 locus of N. crassa 
(Duarte et al., 2004). By confocal microscopy analysis we observed a specific 
accumulation of fluorescence in small dot-like inclusions in the FKBP50::GFP strain 
(Figure 9), likely to be nuclei. Furthermore, these dot like structures were stained with 
DRAQ5 confirming the nuclear location for FKBP50::GFP.  
 
 
GFP DRAQ5 Merge 
 
 
Figure 9. Localization of the fusion protein FKBP50::GFP. Conidia from Neurospora 
strain stably expressing the fusion protein FKBP50::GFP were grown overnight in minimal 
medium containing acetate and subsequently analysed by confocal microscopy for the 
presence of green fluorescence. The nuclei were stained with DRAQ5. 
 
 
To confirm that the endogenous FKBP50 is also located in the nucleus we grew the 
wild type strain in minimal medium and isolated several organelles. Through a Western 
blotting analysis using specific antiserum against the FKBP50 we confirmed that the 
FKBP50 is indeed a nuclear protein (Figure 10). The FKBP50 appears in distinct bands 
possibly as a result of post-translational modifications, as phosphorylation. The upper band 
that appears in all lanes, including in the fkbp50 mutants (Figure 10), is a cross reaction of 
the antibody. As depicted in Figure 10, FKBP13 localizes in the cytoplasm and 
mitochondria although it is located essentially in the cytoplasm, confirming the previously 
described dual localization (Tropschug et al., 1990; Tropschug, 1997). As control for 
organelle purification we used antisera against the ER protein FKBP22 (Solscheid and 
Tropschug, 2000) (Figure 10) and the 14 kDa mitochondrial protein of complex I (Marques 
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et al., 2005) (Figure 10). The cytoplasm represents what is left after cellular fractionation, 
so that it is possible to find remains of FKBP22 in this last fraction.  
FKBP11 was not detectable in the wild type strain at different temperatures, diverse 
carbon sources and several stress conditions. In order to overcome this initial barrier we 
constructed a strain overexpressing FKBP11. The pMF272 plasmid presents an inducible 
promoter (ccg-1) that is repressed by glucose and induced by glucose absence or by stress 
conditions. Usually to obtain a greater protein expression we substitute the glucose carbon 
source by sodium acetate. In this case we observed that the fkbp11 expression was not 
altered by the use of glucose or sodium acetate, so we grew the OEFKBP11 strain in 
minimal medium at 26ºC and isolated several organelles. Analysis of the different cellular 
fractions by Western blotting shows that FKBP11 is exclusively a cytosolic protein (Figure 
10).     
 
 
 
 
Figure 10. Cellular location of the FKBPs from N. crassa. Wild type cellular extracts 
were prepared and the cellular fractions analysed by Western blotting using specific 
antisera as indicated in the left side. For the location of FKBP11 the organelles were 
purified from the OEFKBP11 strain.  The 14 kDa subunit of complex I (CI) was used as 
control. ET – total cellular extracts; N – nuclei; M – mitochondria; ER – endoplasmic 
reticulum; S – components of the cytoplasm after cellular fractionation. In each panel, MT 
represents total cellular extracts obtained from null-mutant strains corresponding to the 
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protein being analysed. Approximately 200µg of protein were loaded in the lanes 
corresponding to total extracts and cytoplasm and 50µg on the others. 
 
 
3.3 The OEFKBP11 strain is resistant to high levels of calcium and zinc 
 
As mentioned before, to localize the FKBP11 protein we grew the wild type strain 
with various carbon sources (1,5% sucrose, 44mM sodium acetate and 2% glycerol), 
different temperatures (26ºC and 37ºC) and different stress conditions, including 
starvation, osmotic stress (1M NaCl and 1M sorbitol), oxidative stress (0,5 to 2mM H2O2) 
and protein misfolding (2,5mM L-Azetidine-2-carboxylic acid). We also tested for the 
presence of the FKBP11 during several stages of the vegetative development as mycelium, 
aerial hyphae and conidia. In none of the conditions tested we detected the presence of the 
FKBP11.  
Since the FKBP11 is not detected during vegetative development of the fungus and 
the ∆fkbp11 mutant shows no visible phenotype we decided to test if the overexpression of 
the FKBP11 conducted to any alteration of the cellular functioning. To that purpose the 
OEFKBP11 strain was grown in plates containing solid sorbose medium (GFS) with 
different stress conditions induced by 1,5mM H2O2, 200μM paraquat, 2,5mM L-azetidine-
2-carboxylic acid, 50mM LiCl, 100mM CaCl2 and 4mM ZnCl2. Surprisingly, the 
OEFKBP11 strain presented a different phenotype when grown in GFS supplemented with 
100mM CaCl2 and 4mM ZnCl2. In both situations the OEFKBP11 strain produced larger 
colonies when compared to the wild type strain (Figure 11). Apparently this phenotype is 
not due to a chloride effect since the strain growing in 50mM LiCl did not present the same 
phenotype (Figure 11). Calcium is one of the most important second messengers as its 
levels change in response to many cellular alterations. The presence of the FKBP11 
appears to give an advantage to the strain, indicating that the FKBP11 could be involved in 
calcium regulation. However, linear growth in race tubes is comparable in strains, wild 
type and OEFKBP11, in media containing CaCl2 and ZnCl2. 
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WT 
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Figure 11. The OEFKBP11 strain is resistant to high amounts of CaCl2 and ZnCl2. 
Five microliters  of serial dilutions of conidia from the indicated strains were inoculated 
(spotted) onto solid sorbose medium (GFS) supplemented with 100mM CaCl2, 4mM ZnCl2 
or 50mM LiCl and incubated at 37ºC for approximately 48 hours. 
 
 
To test if these stress agents induce the expression of the FKBP11 we grew the wild 
type and the OEFKBP11 strains in liquid minimal medium supplemented with 100mM 
CaCl2 and 4mM ZnCl2. The OEFKBP11 showed an increased in the expression of the 
FKBP11 in media containing CaCl2 when compared to the control and media containing 
ZnCl2. Interestingly, the FKBP11 was detected in the wild type growing with CaCl2, but 
not when this strain was grown with ZnCl2 (Figure 12). If the protein has an important role 
in the regulation of the intracellular levels of calcium or zinc we would expect to detect the 
protein in the wild type strain growing in the same conditions, which only happen with 
calcium. However, the amount of FKBP11 present in any of these situations can probably 
explain the phenotype observed for OEFKBP11. The overexpression of the FKBP11 
appears to give an advantage to the strain in some stress conditions promoting a larger cell 
proliferation despite that the protein is not important to the survival of the wild type strain 
in the same conditions. 
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OEFKBP11 Wild type 
           Cont     CaCl2    ZnCl2      Cont     CaCl2      ZnCl2 
        
FKBP11 
14 kDa CI 
      
Figure 12. Calcium induces the expression of FKBP11. The wild type and the 
OEFKBP11 strains were grown in minimal medium supplemented with 100mM CaCl2 or 
4mM ZnCl2. Expression of the protein FKBP11 was analysed by Western blotting using an 
antiserum against the protein. The 14 kDa subunit of complex I (CI) was used as loading 
control. Approximately 300µg of protein were loaded in each lane. 
 
 
3.4 The FKBP11 is highly expressed during sexual development 
 
N. crassa is a heterothallic filamentous fungus that presents both asexual and sexual 
reproduction. The decision whether to undergo asexual or sexual development is made 
based on environmental signals. Usually reproducing asexually, in situations of nitrogen 
starvation, low light and temperature Neurospora undergoes a complex pattern of sexual 
differentiation to form the female reproductive structure, the protoperithecium. After 
fertilization by a nucleus of the opposite mating-type, the protoperithecium develops into a 
fruiting body called perithecium, which contains the asci with the ascospores (Nelson and 
Metzenberg, 1992; Coppin et al., 1997; Davies, 2000; Kim and Nelson, 2005). Since 
FKBP11 is not expressed during the vegetative phase of growth of N. crassa, we decided 
to investigate its expression during sexual development. For that propose we grew the wild 
type strain in liquid Westergaard medium at 26ºC, prepared  protein full-extracts and 
analysed the FKBP11 expression by Western blotting. We found that FKBP11 is highly 
expressed in N. crassa growing in Westergaard medium, a medium poor in nitrogen used 
to promote sexual development (Figure 13). We further observed that this high expression 
is not dependent in the nitrogen concentration but it’s prevented at 37ºC, a condition that 
also impairs the development of fungal perithecia (Perkins, 1987). To determine if the 
FKBP11 play an important role in the sexual cycle of N. crassa we tested the fertility of 
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the ∆fkbp11 mutants, as female and male, with both wild type strains. When compared 
with the wild type, none of the displayed any defect in terms of the development of sexual 
structures (formation of protoperithecia and perithecia), producing viable black ascospores. 
Thus, although the fkbp11 gene is expressed during the sexual development, it appears not 
to be a gene essential for the process. As known for other FKBPs (and cyclophilins) that 
are involved in multiple cellular processes, it is possible that the protein encoded by fkbp11 
has a redundant function or that its absence might be covered by the presence of other 
proteins. To date, no gene encoding a FKBP or cyclophilin involved in sexual development 
in filamentous fungi has been identified. 
 
 
 Wild type OEFKBP11 
                 Control  CaCl2   ZnCl2   West   Control CaCl2     ZnCl2 
 FKBP11 
 
CIII  
 
Figure 13. FKBP11 expression is also induced in Westergaard medium. The wild type 
and the OEFKBP11 strains were grown in minimal medium supplemented with 100mM 
CaCl2 or 4mM ZnCl2. Moreover the wild type was also grown is Westergaard medium 
(West). Expression of the protein FKBP11 was analysed by Western blotting using an 
antiserum against the protein. As loading control we used a mitochondrial complex III 
protein (CIII). Approximately 250µg of protein were loaded in all lanes. 
 
 
3.5 FKBP13 is resistant to protease degradation 
 
With the purpose to confirm where the FKBP13 was located in mitochondria we 
preformed a protease accessibility assay based on the sequential solubilization of 
mitochondria with digitonin (DIG) (Carneiro et al., 2007).  In this assay approximately 100 
µg of wild type mitochondria were solubilized with increasing concentrations of DIG and 
the several fractions obtained subjected to a proteinase K (PK) treatment. Even though 
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when we analyzed the FKBP13 sequence in the PeptideCutter program we could find forty 
eight PK restriction sites, in this assay we verified that FKBP13 was completely resistant 
to PK degradation. To test if this result was due to a problem related to a deficient 
mitochondria solubilization, we solubilized wild type mitochondria with other detergents, 
as Triton X-100 and SDS, and tested the FKBP13 sensitivity to high amounts of PK and 
trypsin (Tryp). As control we used a mitochondrial complex III protein (CIII) and the His-
FKBP13 fusion protein produced in E. coli (Figure 14A). In contrast to the control proteins 
that were completely digested by both proteases, when mitochondria were solubilized with 
1% Triton X-100 the FKBP13 was found to be highly resistant to PK degradation and 
partially sensitive to Tryp proteolysis (Figure 14A). On the other hand, when mitochondria 
were solubilized with a more aggressive detergent as SDS, an anionic surfactant that 
disrupts all the non-covalent bonds leading to protein denaturation, we verified that 
FKBP13 was more sensitive to PK and Tryp degradation. In order to determine if the 
cytosolic FKBP13 presented the same protease sensitivity we repeated the assay using 
cytoplasm obtained after mitochondria isolation, for that reason we used FKBP22 as 
control in this assay. In opposite to the result obtained with mitochondria, the cytosolic 
FKBP13 was completely resistant to PK degradation in both conditions tested (Figure 
14B). A higher resistance to Tryp degradation was also observed, although we could 
identify fifteen Tryp restriction sites in FKBP13 using the PeptideCutter program.  
Proteins resistant to PK proteolysis are rare mostly due to the potency, wide pH 
optimum and low peptide bond specificity of this protein. Since PK is a more aggressive 
protease, when compared to Tryp, we would expect to find a higher or even total 
sensitivity of FKBP13 to this protease. The FKBP13 high stability upon protease 
degradation can eventually be a result of post-translational modifications. For example, it 
is known that the sarcoplasmic reticulum Ca2+-ATPase when unphosphorylated is highly 
sensitive to PK, Tryp and V8 protease degradation (Danko et al., 2001). In opposite, ADP-
insensitive phosphoenzyme and phosphorylated state analogues display a more compact 
conformation being almost completely resistant to degradation by these proteins. This 
hypothesis is reinforced by the fact that the His-FKBP13 produced in E. coli, where no 
post-translational modifications occur, is completely sensitive to protease degradation 
(Figure 14 A). The differential protease resistance may represent a physiological regulatory 
mechanism controlling the functions of the FKBP13.  
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Figure 14. FKBP13 is resistant to protease degradation. A. Approximatelly 100μg of 
wild type mitochondria were solubilized with 1% Triton X-100 (TX-100) or 0,5% sodium 
dodecyl sulfate (SDS) and the FKBP13 sensitivity to protease degradation tested by 
different concentrations of proteinase K (PK) and trypsin (Tryp). The His-FKBP13 fusion 
protein and a mitochondrial complex III protein (CIII) were used as control. B The same 
assay was used in the determination of the sensitivity of citosolic FKBP13 to protease 
degradation. As control it was used the FKBP22. Cont – control; protein solubilized with 
the respective detergent but not subjected to protease degradation. 
 
 
 
 
 
ET Cont   30  45   30   45 Cont  30  45  30   45     Cont   30   45    30    45         
FKBP13 
CIII 
B 
Citoplasm 
Cont    30   45   30   45 Cont 30  45   30   45  Cont 30  45    30    45    
     1% TX-100                  0,5% SDS
       PK        Tryp              PK       Tryp               PK        Tryp        
FKBP13 
FKBP22 
39 
 
3.6 A protein of 40 kDa coimmunoprecipitates with As-FKBP13  
 
In addition to their involvement in protein folding, most of the PPIases interact with 
restricted cellular partners, being thus involved in specific cellular processes. For that 
reason, the identification of the N. crassa FKBPs potential cellular partners is an important 
step in order to understand the physiological role of these proteins. In an attempt to identify 
the cellular partners of the N. crassa FKBP13 we performed immunoprecipitation 
experiments using an antiserum against this protein. In these experiments, the wild type 
and ∆fkbp13 mutant full-extracts and mitochondrial proteins were solubilized with 
different detergents as Triton X-100, DIG and n-dodecyl-β-D-maltoside (DDM) and 
incubated with FKBP13 antiserum overnight. In contrast to the nonionic surfactant Triton 
X-100 that virtually disrupts all protein interactions, the detergents DIG and DDM are less 
aggressive preserving the more instable protein associations. The samples resulted from the 
immunoprecipitation experiments were subjected to a SDS-PAGE and the resulting gel 
silver stained.  
In all the conditions tested it was possible to immunoprecipitate both the cytosolic 
and the mitochondrial FKBP13, being this result confirmed by Western blotting (Figure 
15). Along with the FKBP13 it was also coimmunoprecipitated a protein of approximately 
40 kDa in the fractions corresponding to full-extracts solubilized with DIG or DDM 
(Figure 15, indicated by the arrow). In opposition to Triton X-100, an aggressive nonionic 
surfactant, the mild non-ionic detergent DIG and the gentle detergent DDM are frequently 
used to solubilize receptors and permeabilize cellular and nuclear membranes, preserving 
the protein activity and the weak protein associations. This 40 kDa protein could only be 
immunoprecipitated using these less aggressive detergents, suggesting that FKBP13 may 
interact with a cytosolic protein through weak interactions. The isolation and identification 
of the 40 kDa protein may provide us new insights about the cellular function of FKBP13. 
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Figure 15. FKBP13 coimmunoprecipitates with a protein of approximately 40 kDa. A. 
Approximately 1,5 mg of wild type and ∆fkbp13 full-extracts (ET) and mitochondrial 
(Mito) proteins were solubilized with 0,5% Triton X-100 (TX-100), 0,5% digitonin (DIG) 
or 0,5% n-dodecyl-β-D-maltoside (DDM) and incubated with an antiserum against the N. 
crassa FKBP13. Approximately 200µg of protein were subjected to a 17,5% SDS–PAGE 
and the resulting gel stained with silver. B. The same fractions were analysed by Western 
blotting using an antiserum against the FKBP13 protein. 
 
 
3.7 N. crassa FKBPs amounts changes in response to stress conditions 
 
In order to analyse the response of the N. crassa FKBPs to different stress conditions 
and the possible interaction of the FKBP11 with the remaining proteins, we grew the 
strains wild type and OEFKBP11 in VMM for approximately 16 hours and incubated the 
strains for an additional 4 hours and 30 minutes with several stress inducers. Protein full-
extracts of all the conditions were prepared and analysed by Western blotting using 
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antisera against all the FKBP proteins. As loading control we used an antiserum against the 
mitochondrial protein COREII.  
As shown in figures 16A and B, when compared to the control VMM, the FKBP50 
can be found in slighty amounts in the wild type strain grown at 26ºC with ZnCl2, the 
proline analogue L-azetidine-2-carboxylic (AZ) acid and sorbitol. As the heat-shock and 
the hyper-osmotic stresses, the incorporation of the L-proline analogue L-azetidine-2-
carboxylic acid during translation induces protein misfolding. This protein levels are also 
increased in the OEFKBP11 strain grown in VMM and VMM supplemented with ZnCl2. 
Interestingly, the FKBP50 is almost completely absent in the wild type and OEFKBP11 
strains grown with CaCl2, suggesting that fkbp50 expression might be down regulated by 
calcium.   
As the FKBP50, at 26ºC the FKBP22 can be found more expressed in stress 
conditions that induce protein misfolding as osmotic stress promoted by high levels of 
NaCl and sorbitol, oxidative stress induced by the herbicide paraquat and ZnCl2 and 
protein misfolding caused by AZ, which correlates with its ER chaperone activity. 
Curiously, as the FKBP50, the FKBP22 can be detected in high amounts in the 
OEFKBP11 strain grown with VMM and VMM supplemented with ZnCl2, but not when 
this strain was grown with CaCl2 (Figure 16A). At 37ºC, the FKBP22 is in general more 
expressed possibly as an effect of the heat-shock stress, even when the OEFKBP11 was 
grown with CaCl2. 
At 26ºC, the FKBP13 levels were found to be significantly reduced when the wild 
type was grown with ZnCl2, paraquat, LiCl or AZ. In contrast, the FKBP13 levels were 
considerably higher in the OEFKBP11 strain grown with CaCl2, situation were the 
FKBP11 levels are very high, suggesting a possible relation between FKBP13 and 
FKBP11 (Figure 16A). At 37ºC, the FKBP13 levels are not significantly altered in any of 
the conditions tested (Figure 16B).  
In wild type, the FKBP11 can be detected when this strain grows at 26ºC with high 
amounts of calcium or with Westergaard medium (Figure 16A). On the contrary, the 
FKBP11 cannot be detected when the wild type grows in Westergaard medium at 37ºC, 
correlating a possible involvement of this protein in sexual development, which does not 
occur or occur deficiently at high temperatures (Perkins, 1986) (Figure 16B).   
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Figure 16. Effect of different stress inducers in the FKBPs levels. The wild type and 
OEFKBP11 strains were grow in VMM medium for approximately 16 hours and 
additionally incubated for 4 hours and a half with several stress inducers. The results were 
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analysed by Western blotting using antisera against the FKBP proteins as indicated on the 
left side. Approximately 250µg of protein were loaded in each lane. As loading control we 
used the mitochondrial protein COREII. A. Growth at 26ºC. B. Growth at 37ºC. 
 
 
3.8 Production of FKBP multiple mutants 
 
In order to investigate the specific role of FKBPs, we generated multiple mutants for 
the fkbp genes. The double, triple and quadruple mutants were obtained by crossing the 
single (∆fkbp11, ∆fkbp13, fkbp22RIP and fkbp50RIP) and multiple (fkbp22/50 and 
fkbp13/22/50) N. crassa mutants in solid Westergaard medium, a synthetic medium poor 
in nitrogen that favours sexual reproduction (Westergaard and Mitchell, 1947). The cross 
between mutants was initiated with the inoculation of one of the mutants (the one serving 
as female) in plates containing Westergaard medium. After three days of growth at 26ºC, 
the second mutant of the opposite mating-type (the one serving as male) was inoculated in 
the same plate. After approximately two weeks of growth it was possible to observe the 
development of sexual structures (perithecia) and the release of the spores. Seven days 
after the release, the mature spores were collected and activated by heat shock at 60ºC. The 
activated spores were plated in GFS medium and five days later several colonies isolated. 
The identification of ∆fkbp11 mutants among ascospore progeny of the crosses was carried 
out by Southern blot analysis. The multiple mutants for the genes fkbp13, fkbp22 and 
fkbp50 were identified by immunoblotting analysis with specific antisera against the 
respective proteins.  
In Figure 17 are displayed some of the different mutant combinations obtained with 
the cross of ∆fkbp13 and fkbp22/50 mutants. During the germination of spores isolated 
from this cross it was possible to observe the existence of both small and large colonies. 
Protein full-extracts from both types of colonies isolated were analyzed by Western 
blotting using specific antisera against the FKBP13, FKBP22 and FKBP50 proteins in 
order to identify the respective mutants. Interestingly, through immunoblotting it was 
possible to determine that all the small colonies isolated were fkbp50 mutants. Although 
viable, all the single, double and triple mutants lacking the fkbp50 gene presented a spore 
germination delay. In contrast, none of the strains isolated from the larger colonies were 
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fkbp50 mutants, associating this phenotype to the mutation of the fkbp50 gene. Since we 
were not able to detect the FKBP11 by Western blotting, the identification of ∆fkbp11 
mutants resulting from the crosses ∆fkbp11 x fkbp13/50 and ∆fkbp11 x fkbp13/22/50 was 
performed by Southern blotting as described in material and methods.  
In table 3 is summarized the number and mutant genotypes obtained in the different 
crosses analyzed. The construction of the N. crassa fkbp mutant collection was relatively 
easy to obtain mainly due to the fact that all the genes are located in different 
chromosomes and none of the deletions revealed to be lethal to the different mutant strains.  
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Figure 17. N. crassa mutants resulting from the cross ∆fkbp13 x fkbp22/50. In order to 
obtain multiple mutants for the fkbp13, fkbp22 and fkbp50 genes, the mutants ∆fkbp13 and 
fkbp22/50 were crossed in solid Westergaard medium. The progeny of the cross was 
analyzed by Western blotting using specific antisera against FKBP13, FKBP22 and 
FKBP50. The FKBP50 protein appears in two distinctive bands.   
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 Crosses Number of spores analyzed Genotypes obtained 
∆fkbp13 x fkbp50RIP 8 
fkbp50 (2)* 
fkbp13/50 (6)* 
∆fkbp13 x fkbp22RIP 10 
WT (2) 
fkbp13 (4) 
fkbp22 (4) 
fkbp13/22 (1) 
∆fkbp13 x fkbp22/50 21 
WT (1) 
fkbp22 (2) 
fkbp50 (5) 
fkbp13/22 (4) 
fkbp13/50 (3) 
fkbp22/50 (4) 
fkbp13/22/50 (2) 
∆fkbp11 x fkbp13/50 4 
fkbp11 (1) 
fkbp13 (1) 
fkbp11/13 (1) 
fkbp11/13/50 (1) 
∆fkbp11 x fkbp13/22/50 19 
fkbp22 (1) 
fkbp50 (1) 
fkbp11/22 (3) 
fkbp11/50 (4) 
fkbp13/22 (1) 
fkbp22/50 (2) 
fkbp11/13/22 (2) 
fkbp11/22/50 (1) 
fkbp13/22/50 (1) 
fkbp11/13/22/50 (3) 
Table 3. N. crassa fkbp mutants. In order to complete the N. crassa fkbp mutant 
collection, single and multiple mutants were crossed in Westergaard medium and the 
progeny analyzed by Western and Southern blotting. In the table are represented the 
mutants obtained in some of the crosses performed during this study. In brackets are 
displayed the number of mutants obtained per cross. *In this cross only small colonies 
were isolated. 
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3.9 Disruption of FKBP50 leads to a temperature-sensitive phenotype 
 
Previous works have shown that FKBPs are not important for survival of different 
species. In a search for the physiological role of the N. crassa FKBPs we grew the single 
mutants ∆fkbp11, ∆fkbp13, fkbp22RIP and fkbp50RIP in race tubes with different carbon 
sources (1,5% sucrose, 44mM sodium acetate and 2% glycerol) and different stress 
conditions (1,5 to 2mM H2O2, 200μM paraquat, 1M NaCl, 1M sorbitol and 2,5mM L-
azetidine-2-carboxylic acid) under two temperatures (26 and 37ºC). We observed that the 
∆fkbp11, ∆fkbp13 and fkbp22RIP mutants showed no detectable phenotype (Figure 18A). 
Since the endogenous FKBP11 protein is not detected in any of the conditions tested 
before, the lack of a phenotype for ∆fkbp11 was expected. However, the non-existence of a 
visible phenotype for the ∆fkbp13 mutant could be due to a redundancy of functions 
between similar proteins. For instance, like FKBP13 the N. crassa cyclophilin 20 (Cyp20) 
is also located both in mitochondria and cytoplasm (Tropschug et al., 1988; Rassow et al., 
1995). Although Cyp20 is not involved in the import of preproteins into mitochondria, this 
protein is an active component of the protein folding machinery as it promotes protein 
folding in the mitochondrial matrix in an association with the molecular chaperones Hsp70 
and Hsp60 (Rassow et al., 1995).  
Previously it was observed that the fkbp50RIP mutant displayed a growth defect when 
grown at 26ºC. Therefore, we carried out a detailed analysis of the fkbp50RIP mutant 
growth in race tubes containing VMM at two different temperatures. Contrary to the wild 
type and the other fkbp mutants, and confirming the previous result, we observed that the 
fkbp50RIP mutant presented a notorious growth defect when grown at 26ºC (Figure 18B). 
Interestingly, this growth deficiency was almost completely reversed when the strain was 
grown at 37ºC. To verify if this phenotype was a result of the fkbp50 disruption and not a 
consequence of any secondary effect of the RIPing phenomenon, we tested the ∆fkbp50 
mutant in the same conditions. We verified that both fkbp50 mutants displayed the 
temperature-sensitive phenotype at 26ºC that was almost completely overturned when the 
strains were grown at 37ºC (Figure 18B). It is likely that the cellular stress caused by the 
heat shock may partially compensate for the FKBP50 defect. FKBP50 is homologous to 
Fpr4 a nucleolar protein that consists of an acidic domain in the N-terminus, a basic 
domain in the middle and the PPIase domain at the C-terminus. Recent studies demonstrate 
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that Fpr4 possesses a novel histone chaperone activity, acting as a chromatin component 
involved in rDNA silencing (Kuzuhara and Horikoshi, 2004). The acidic domain is 
responsible for the histone chaperone activity while the PPIase domain inhibits this activity 
(Xiao et al., 2006). In addition, Fpr4 was described as a histone proline isomerase, whose 
activity regulates methylation of lysine 38 in histone H3 and the induction of transcription 
(Nelson et al., 2006). Based on the homology of FKBP50 and Fpr4 it is possible that the 
Neurospora enzyme is also involved in similar processes. Considering that N. crassa 
FKBP50 is involved in rDNA silencing, disruption of the fkbp50 gene may lead to the lack 
of repression of the genes encoding ribosomal proteins, which conducts to an alteration of 
the normal cellular function and the observation of the fkbp50 phenotype. It is described 
that stress imposed by heat shock leads to the repression of genes encoding ribosomal 
proteins (Trotter et al., 2002), in this way, the partial reversion of the fkbp50 phenotype 
may be explained by the growth of the mutant at high temperatures (37ºC). Silencing of the 
rDNA and/or the induction of several genes could be the reasons for the partial reversion 
of the growth defect by temperature increase (Nelson et al., 2006). 
Disruption of all four FKBP immunophilins did not affect the fungus viability, 
showing that all of these proteins are dispensable for N. crassa survival (Figure 18A). With 
the exception of the multiple mutants carrying the fkbp50 mutation, which maintained the 
growth deficiency, none of the other mutant combinations presented a detectable 
phenotype in what concerns growth, temperature-sensitivity, oxidative stress or the 
presence of a protein misfolding inducer (L-azetidine-2-carboxylic acid). 
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Figure 18. Effect of the temperature on the growth of different strains of N. crassa. A. 
The wild type (□) and mutants ∆fkbp11 (◊), ∆fkbp13 (∆) and fkbp22RIP (○) and 
∆fkbp11/13/22/50 (♦) were inoculated (5x104 conidia/5µl) in race tubes with minimal 
medium and grown at two different temperatures. B. Growth of fkbp50RIP (◊) and ∆fkbp50 
(∆) mutants compared to the wild type (□). 
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 Chapter 4. Final remarks  
 
In addition to their role in protein folding, several studies report the involvement of 
immunophilins in key regulatory mechanisms, as control of transcription, cell-cycle 
regulation and apoptosis (Lu et al., 1996; Arévalo-Rodrígues and Heitman, 2005; Baines et 
al., 2005). Due to their high conservation, the characterization of the cellular mechanisms 
mediated by these proteins using low eukaryotes as a model study might help us to 
understand essential cellular processes.  
In this study we proposed to characterize the cellular functions of three 
immunophilins of the FKBP family identified in N. crassa. Our first goal was to establish 
the subcellular location of all the N. crassa FKBPs. Using a GFP fusion protein and wild 
type protein extracts we confirmed the nuclear location of FKBP50, the endoplasmic 
location of FKBP22 and the mitochondrial and cytoplasmic location of FKBP13. We also 
determine that FKBP11 is located in the cytoplasm. A more detailed analysis of these 
proteins showed interesting results. The FKBP11 is only expressed in particular conditions, 
not being detected during the vegetative development of the fungus. This protein can be 
detected when the wild type grows with high amounts of calcium. Interestingly, the strain 
overexpressing FKBP11 is more resistant to high levels of calcium, presenting a larger cell 
proliferation when compared with the wild type. This result may indicate the involvement 
of FKBP11 in calcium regulation. The FKBP11 is also found when the wild strain grows in 
Westergaard medium (a medium favouring sexual reproduction), but only at 26ºC. It is 
known that at high temperatures Neurospora sexual development does not occur or occurs 
deficiently. This result reinforces the potential involvement of FKBP11 in sexual 
development, although disruption of the fkbp11 gene does not affect the development of 
sexual structures, as protoperithecia and perithecia, or the production of viable ascospores. 
As the N. crassa immunophilin Cyp20, the FKBP13 presents dual location, being found 
simultaneously in mitochondria and cytoplasm. Treatment of wild type protein extracts 
with different proteases showed that FKBP13 is highly resistant to proteolysis, specially 
the cytoplasmic FKBP13. Post-translational modifications, as phosphorylation, may be in 
the origin of the resistance of this protein to proteolysis. Through immunoprecipitation it 
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was possible to coimmunoprecipitate with FKBP13 a protein of approximately 40 kDa. 
Determination of the cause of resistance to protease degradation and the identification of 
the 40 kDa protein will help us to determine the cellular functions played by this protein. 
The N. crassa nuclear FKBP50 was the only protein which gene mutation lead to a visible 
phenotype. Although disruption of the fkbp11, fkbp13 and fkbp22 genes did not result in a 
detectable phenotype, disruption of the fkbp50 gene resulted in a growth deficiency at 
26ºC, confirmed in this work. Due to the high homology between the N. crassa FKBP50 
and the S. cereviseae Fpr4 we can speculate the involvement of FKBP50 in similar cellular 
events as rDNA silencing. Although the quadruplet mutant presented the fkbp50 disruption 
phenotype, disruption of the four fkbp genes did not affect the fungus viability, showing 
that all four proteins are non-essential for the fungus survival. A final analysis of the 
FKBPs expression in response to several stress inducers suggests that the FKBP50 is down 
regulated by calcium. The FKBP22 levels are found to be high in the majority of the stress 
conditions tested, correlating its function as ER molecular chaperone and the FKBP13 
levels can be found notably high in the presence of high amounts of FKBP11, suggesting a 
possible relation between FKBP13 and FKBP11. 
During the last decades a significant progress has been made towards understanding 
the structure-function relationship of these proteins in the cell. However, the physiological 
roles of the majority of these proteins remain to determine. Although we could not address 
the cellular functions of N. crassa FKBP-type immunophilins, with this work we positively 
contributed to a better knowledge of the factors that influence the activity of these proteins. 
The identification of specific natural ligands and a more profound analysis of the mutant 
strains may provide us new insights into the N. crassa FKBPs physiological role and in a 
more extended way the role of immunophilins in higher eukaryotes.  
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Immunophilins are intracellular receptors of immunosuppressive drugs, carrying peptidyl-prolyl cis–
trans isomerase activity, with a general role in protein folding but also involved in specific regulatory
mechanisms. Four immunophilins of the FKBP-type (FK506-binding proteins) were identified in the gen-
ome of Neurospora crassa. Previously, FKBP22 has been located in the endoplasmic reticulum as part of
chaperone/folding complexes and FKBP13 has been found to have a dual location in the cytoplasm and
mitochondria. FKBP11 is apparently located exclusively in the cytoplasm. It is not expressed during veg-
etative development of the fungus although its expression can be induced with calcium and during sexual
development. Overexpression of the respective gene appears to confer a growth advantage to the fungus
in media containing some divalent ions. FKBP50 is a nuclear protein and its genetic inactivation leads to a
temperature-sensitive phenotype. None of these proteins is, alone or in combination, essential for N.
crassa, as demonstrated by the isolation of a mutant strain lacking all four FKBPs.
 2008 Elsevier Inc. All rights reserved.1. Introduction
Immunophilins are intracellular receptors of immunosuppres-
sive drugs commonly used in the prevention of graft rejection after
organ transplantation and treatment of autoimmune diseases.
According to their affinity to different immunosuppressive drugs
they can be classified in two families: the cyclophilins (CyPs),
which bind cyclosporin A (CsA), and the FK506-binding proteins
(FKBPs), which bind the macrolides FK506 and rapamycin. Along
with the parvulin family, these proteins make part of the larger
protein superfamily of peptidyl-prolyl cis–trans isomerases
(PPIases). The latter activity allows the acceleration of protein fold-
ing (Galat and Metcalfe, 1995; Göthel and Marahiel, 1999; He et al.,
2004; Barik, 2006).
These ubiquitous and highly conserved proteins are found in all
organisms, from archaea to man, and cellular compartments
(Trandinh et al., 1992; Kay, 1996; Galat, 2000; Vallon, 2005). Their
wide distribution and functional conservation lead to a rising curi-
osity and interest in their potential cellular functions. In some
cases it is possible to demonstrate that isomerization of prolyl
bonds is the rate-limiting step in protein folding in vivo andll rights reserved.
tuto de Biologia Molecular
legre 823, 4150-180 Porto,
, Departamento de Química,
7 Porto, Portugal.in vitro (Kiefhaber et al., 1990; Steinmann et al., 1991; Kern et al.,
1995). For instance, it has been found that SurA, a periplasmic pro-
tein in Escherichia coli similar to parvulin is involved in the folding
of periplasmatic and outer membrane proteins in vivo (Lazar and
Kolter, 1996). It is believed that SurA maintains the outer mem-
brane integrity since surA mutants became deformed and easily
lysed during stationary phase. In addition to a general role in
accelerating protein folding, the cellular functions of most of these
proteins are only now being discovered. Recent work has shown a
great number of important and exciting findings implicating these
proteins in key regulatory mechanisms (Luan, 1998; Göthel and
Marahiel, 1999; Breiman and Camus, 2002; Barik, 2006). PPIases
are involved in several and important cellular processes as signal
transduction (Bram et al., 1993), protein trafficking (Stamnes
et al., 1991; Chambraud et al., 2007), protein assembly
(Wu et al., 2004; Xiao et al., 2006), control of transcription
(Arévalo-Rodríguez and Heitman, 2005), pre-mRNA splicing
(Lorkovic et al., 2004), rDNA silencing (Kuzuhara and Horikoshi,
2004), apoptosis (Baines et al., 2005) and cell-cycle regulation
(Lu et al., 1996; Vittorioso et al., 1998).
The yeast Saccharomyces cerevisiae contains four FKBP proteins,
Fpr1 to Fpr4. All yeast prolyl isomerases, with the exception of
Ess1, are individually and collectively dispensable for growth.
However, deletion of the cytoplasmic protein Fpr1 leads to a slow
growth phenotype (Dolinski et al., 1997). Fpr2 is a protein from the
secretory pathway and Fpr3 and Fpr4 are nucleolar proteins. Four
immunophilins belonging to the FKBP family, named FKBP11,
FKBP13, FKBP22 and FKBP50 were also found in the last genome
D. Pinto et al. / Fungal Genetics and Biology 45 (2008) 1600–1607 1601annotation of Neurospora crassa (Neurospora sequencing project,
Whitehead Institute/MIT Center for Genome Research). The
cellular functions of FKBP22 have been recently characterized
(Solscheid and Tropschug, 2000; Tremmel et al., 2007; Tremmel
and Tropschug, 2007). FKBP22 is a homodimeric protein located
in the lumen of the endoplasmic reticulum with a PPIase and a
novel chaperone activity. This protein interacts directly with BiP,
the major HSP70 chaperone in the ER, through its FKBP domain,
being BiP able to enhance FKBP22 chaperone activity. BiP and
FKBP22 form a stable folding helper complex with a high chap-
eroning activity preventing the aggregation of unfolded rhoda-
nese (Tremmel and Tropschug, 2007). FKBP22 appears also to
form other chaperone/folding catalyst complexes with disulfide
isomerases, like ERp38 and PDI, Grp170, another ER HSP70 chap-
erone, and Cyp23, a cyclophilin, being the organization of such
complexes mediated by BiP. FKBP22 is as well involved in the
development of microconidiophores (Tremmel et al., 2007).
FKBP13 was originally isolated from a cytosolic fraction
(Tropschug et al., 1990). Later it was found that an identical pro-
tein can be identified in the mitochondrial matrix, indicating
that FKBP13 has a dual location in N. crassa. Both proteins are
the product of a single nuclear gene, fkr-2. The mitochondrial
protein is synthesized as a precursor with a long presequence
of 56 amino acids, which is cleaved in two steps upon entry into
the mitochondrial matrix (Tropschug, 1997). Mutants in fkr-2
gene lead to the loss of FKBP13 both in cytosol and mitochon-
dria. These mutants are FK506 resistant (Barthelmess and Trops-
chug, 1993), proving that FKBP13 is the major receptor for
FK506 in N. crassa. Although the location of FKBP13 and FKBP22
has been already identified the location of FKBP11 and FKBP50
remained to be determined. Our goal is the characterization of
the role of immunophilins in fundamental cellular processes
common to all eukaryotes. In this work we present the charac-
terization of all N. crassa immunophilins of the FKBP-type.2. Materials and methods
2.1. Neurospora crassa strains and manipulations
The N. crassa strains were grown and handled according to stan-
dard procedures (Davis and de Serres, 1970). The fungal
FGSC#6103 strain, a kind gift from Dr. Michael Freitag (University
of Oregon, USA), was maintained on Vogel’s minimal medium sup-
plemented with 200 lg/ml L-histidine–HCl. The strains Dfkbp11
(FGSC#15831A), Dfkbp13 (FGSC#11562A and FGSC#11563a) and
Dfkbp50 (FGSC#12177a) were obtained from the Fungal Genetic
Stock Center (FGSC), Neurospora Genome Project – Dartmouth
and were maintained in Vogel’s minimal medium containing
100 lg/ml hygromycin B. Mutant fkbp22RIP was handled as previ-
ously described (Tremmel et al., 2007).
For the generation of the fkbp50RIP mutant the fkbp50 gene was
amplified from N. crassa genomic DNA by PCR using the primers
50-GTGGAGTGAACCGTGAGCCT-30 and 50-GGATCCCCTTCCTACCCCA
CGCT-30. The amplified 2356 bp fragment was cloned in the
pGEMT-easy vector (Promega). The resulting plasmid was digested
with XhoI and the relevant band of 1694 bp cloned into pCSN44
treated with the same enzyme, creating plasmid pFKBP50-X. This
recombinant vector was used for transformation of N. crassa 74-
OR8-1a (FGSC) spheroplasts. Genomic DNA from transformants
was analysed by Southern blotting to identify strains with single-
copy integration. One transformant carrying a duplication of the
fkbp50 gene was crossed with strain 74-OR23-1A in order to inac-
tivate this gene by RIP. Identification of fkbp50RIP mutants among
the progeny of the cross was carried out by Western blot analysis
of total proteins with an antiserum against FKBP50.Crosses between single, double and triple mutants were per-
formed on Westergaard’s medium (Westergaard and Mitchell,
1947). Identification of Dfkbp11 mutants among ascospore prog-
eny of the crosses was carried out by Southern blot analysis. The
multiple mutants for the genes fkbp13, fkbp22 and fkbp50 were
identified by immunoblotting analysis with specific antisera
against the respective proteins.
2.2. Cloning experiments
The fkbp11, fkbp13 and fkbp50 cDNAs were amplified from the
M cDNA library (FGSC) by PCR using the primers 11fwd: 50-GG
ATCCaatgggtgtcaacaaaatcactc-30, 11rev: 50-GGATCCcagtgaaccgcc
cagctactg-30, 13fwd: 50-GGATCCgatgactattccccagcttgacg-30, 13rev:
50-GGATCCAATCCGCCTGTATCCCAGAGC-30, 50fwd: 50-CATATGGCC
CCCCTTATGCCTGT-30 and 50rev: 50-GGATCCCCTTCCTACCCCACGC
T-30, respectively. All sets of primers present BamHI restriction
sites, with the exception of the primer 50fwd that presents a NdeI
restriction site (in bold). The PCR products corresponding to fkbp11
and fkbp13 cDNAs were cloned into pCRII-TOPO vectors (Invitro-
gen). The fkbp50 purified cDNA was cloned into the pGEMT-easy
vector (Promega). The constructs were transformed in E. coli
DH5a strain and their sequence verified by DNA sequencing.
In order to determine the subcellular location of the FKBP11
protein, we induced its expression using a plasmid commonly used
to obtain green fluorescent protein (GFP) fusions. For that purpose
the fkbp11 gene was amplified from the genomic DNA, using the
same primers used to amplify the cDNA, and cloned into pCRII-
TOPO vector. The recombinant plasmid pTOPO.gene11 was di-
gested with BamHI and the gene fragment cloned into the
pMF272 plasmid (FGSC). Spheroplasts of the N. crassa FGSC#6103
strain were transformed with the recombinant vector. Genomic
DNA from several transformants was analysed by Southern blot-
ting to identify strains with single-copy integration. One was re-
ferred as OEFKBP11 and used for further analysis.
2.3. Construction and expression of NcFKBP50::GFP fusion protein
To analyse the subcellular location of the FKBP50 protein we
used a green fluorescent protein (GFP) fused to the C-terminus of
the protein. The fkbp50 cDNA lacking the stop codon was amplified
by PCR using the primers F50fwd: 50-GGATCCATGCCTGTCGCCGTT
TTTGGC-30 and F50rev: 50-GGATCCACTTGATCTCAAGGAGCTTGA
CG-30. The amplified 1.4 kb fragment was cloned into pGEMT-easy
vector and the resulting plasmid digested with BamHI to excise the
fkbp50 cDNA band, which was then cloned in frame with the GFP
gene in pMF272 (FGSC). This expression vector was transformed
into the N. crassa FGSC#6103 strain and a single-copy transformant
stably expressing the FKBP50 protein fused to GFP was selected.
Live cells were stained with 0.5 lM DRAQ5 (Biostatus) for visuali-
zation of nuclei and cell images were collected in a Leica Confocal
SP2 using filter sets optimal for GFP and DRAQ5 red fluorescence
(Leica Microsystems).
2.4. Production of polyclonal antibodies
The recombinant plasmids pTOPO.cDNA11 and pTOPO.cDNA13
were digested with BamHI and the cDNA fragments subcloned into
pQE31 (Qiagen) and pET28b (Novagen) vectors, respectively. The
pGEMT.cDNA50 was double digested with NdeI and BamHI and
subcloned into the pET19b (Novagen) expression vector. For the
expression of the His-FKBP13 recombinant protein the strain used
as host was E. coli M15 (Qiagen). The His-FKBP11 and His-FKBP50
recombinant proteins were expressed in E. coli BL21(DE3) strain
(Stratagene). The expression of His-tag fusion proteins was in-
duced by 1 mM IPTG for 3 h at 37 C and the purification of recom-
1602 D. Pinto et al. / Fungal Genetics and Biology 45 (2008) 1600–1607binant proteins was performed using a His-TrapTM HP column (GE
Healthcare). The His-tag fusion proteins were used to produce
rabbit polyclonal antisera as described previously (Videira and
Werner, 1989).
2.5. Miscellaneous
The techniques used for PCR and general cloning (Sambrook and
Russell, 2001), protein determination (Bradford, 1976), SDS–poly-
acrylamide gel electrophoresis (Zauner et al., 1985), Western
(Towbin et al., 1979) and Southern blot (Southern, 1975) have been
published before. The N. crassa preparation of total extracts and
isolation of nuclei (Hautala et al., 1977), mitochondria, endoplas-
mic reticulum and cytoplasm was performed as described
(Borgeson and Bowman, 1983). The Broad Institute Accession num-
bers for the FKBP11, FKBP13, FKBP22 and FKBP50 proteins are
NCU04371.3, NCU04140.3, NCU02455.3 and NCU03241.3,
respectively.3. Results and discussion
3.1. Cloning and disruption of FKBP genes
For the production of antibodies against the FKBP11, FKBP13
and FKBP50 proteins, we designed primers based on the gene se-
quences of the three fkbp genes (fkr-3, fkr-2 and fkr-4) available
at the Broad Institute (http://www.broad.mit.edu/annotation/gen-
ome/neurospora) and amplified the respective cDNAs by PCR. For
FKBP13 only the 120 C-terminal amino acids were considered
based on the previously described sequence (Tropschug et al.,
1990). The sequencing results were aligned with the respective
genomic sequences using the Blast program. The sequencing re-
sults related to the fkbp13 and fkbp50 cDNAs showed no differ-
ences to the cDNA sequences annotated. When we analysed the
amplified fkbp11 cDNA sequence we verified that three codons ini-
tially annotated as the final part of the first intron sequence are in
fact the beginning of the second exon (Fig. 1a). Two of the codons
code for the amino acids glutamate and phenylalanine (this se-
quence provides a recognition site for the restriction enzyme Eco-
RI) and the third codon encodes the amino acid serine.
Characteristics arising from in silico analysis of the different fkbp
genes and proteins are displayed in Fig. 1b and c.
In order to investigate the specific role of FKBPs, we generated
a null-mutant strain by inducing mutations in the fkbp50 gene, as
described in material and methods. Fig. 2a shows the results of
Southern blots obtained with the single-copy transformant T12.
Using the enzyme SacI two bands of 1.5 and 5.9 kb can be de-
tected in the wild type DNA. The same enzyme leads to the
appearance of two extra bands of 4.4 and 6.8 kb in DNA from
transformant T12. With PvuII a single band of 6.4 kb in wild type
and an extra band of 5.7 kb in T12 are visible. A 1.7 kb band is
visible in wild type and T12 when XhoI is used (the enzyme used
for cloning in pCSN44, not shown) indicating that the ectopic
DNA fragment is intact. Altogether, these results indicate that a
single-copy gene that has been duplicated in transformant T12
encodes the FKBP50 protein. The strain T12 was then crossed
with a wild type strain to generate fkbp50 mutants that were
identified between the progeny by Western blot analysis of total
extracts with antisera against FKBP50 (Fig. 2b). The fkbp22 mu-
tant was described before (Tremmel et al., 2007) and the fkbp11
and fkbp13 deletion mutants were obtained from the FGSC (Colot
et al., 2006). Double, triple and quadruple mutants were obtained
by crosses of the single and multiple mutants and their identifica-
tion was performed by Western and/or Southern blotting
analysis.3.2. Cellular location of FKBPs
In this work we have confirmed the FKBP13 dual location and
determined the subcellular location of the proteins FKBP11 and
FKBP50. To determine the subcellular location of FKBP50, we first
used a green fluorescent protein (GFP) fusion. The cDNA encoding
FKBP50 was cloned in frame with the GFP gene, under the control
of an inducible promoter. The fusion construct was targeted to the
his-3 locus of N. crassa. By confocal microscopy analysis we ob-
served a specific accumulation of fluorescence in small dot-like
inclusions in the FKBP50::GFP strain (Fig. 3a), likely to be nuclei.
Furthermore, these dot-like structures were stained with DRAQ5
confirming the nuclear location for FKBP50::GFP. To confirm that
the endogenous FKBP50 is also located in the nucleus we grew
the wild type in minimal medium and isolated several organelles.
Through a Western blotting analysis using specific antisera against
the FKBP50 we confirmed that the FKBP50 is indeed a nuclear pro-
tein (Fig. 3b). The FKBP50 appears in distinct bands possibly as a
result of post-translational modifications. The upper band that ap-
pears in all lanes, including the fkbp50 mutants (Fig. 3b), is a cross
reaction of the antibody.
As depicted in Fig. 3b, FKBP13 localizes in the cytoplasm and
mitochondria although it is located essentially in the cytoplasm,
confirming the previously described dual localization (Tropschug
et al., 1990; Tropschug, 1997). As control for organelle purification
we used antisera against the ER protein FKBP22 (Solscheid and
Tropschug, 2000) and the 14 kDa mitochondrial protein of complex
I (Marques et al., 2005) (Fig. 3b). The cytoplasm represents what is
left after cellular fractionation, so that it is possible to find remains
of FKBP22 in this last fraction.
FKBP11 was not detectable in the wild type strain at different
temperatures, diverse carbon sources and several stress conditions
(data not shown). In order to overcome this initial barrier we
amplified the fkbp11 gene from genomic DNA by PCR. The gene
fragment was cloned into the pMF272 plasmid and the construct
obtained used to transform spheroplasts of a N. crassa histidine
mutant strain. The pMF272 plasmid presents an inducible pro-
moter (ccg-1) that is repressed by glucose and induced by glucose
absence or by stress conditions. Usually to obtain a greater protein
expression we substitute the glucose carbon source by sodium ace-
tate. In this case we observed that the fkbp11 expression was not
altered by the use of glucose or sodium acetate (data not shown),
so we grew the OEFKBP11 strain in minimal medium at 26 C
and isolated several organelles. Analysis of the different cellular
fractions by Western blotting indicates that FKBP11 is exclusively
a cytosolic protein (Fig. 3b).
3.3. Disruption of FKBP50 leads to a temperature-sensitive phenotype
Previous works have shown that FKBPs are not important for
survival of different species. In a search for the physiological role
of the N. crassa FKBPs we grew the single mutants Dfkbp11,
Dfkbp13, fkbp22RIP and fkbp50RIP in race tubes with different car-
bon sources (1.5% sucrose, 44 mM sodium acetate and 2% glycerol)
and different stress conditions (1.5–2 mM H2O2, 200 lM paraquat,
1 M NaCl, 1 M sorbitol and 2.5 mM L-azetidine-2-carboxylic acid)
under two temperatures (26 and 37 C). We verified that the
Dfkbp11, Dfkbp13 and fkbp22RIP mutants showed no detectable
phenotype (Fig. 4a). Since the endogenous FKBP11 protein is not
detected in any of the conditions tested before, the lack of a pheno-
type for Dfkbp11 was expected. However, the non-existence of a
visible phenotype for theDfkbp13 mutant could be due to a redun-
dancy of functions between similar proteins. For instance, like
FKBP13 the N. crassa cyclophilin 20 (Cyp20) is also located both
in mitochondria and cytoplasm (Tropschug et al., 1988; Rassow
et al., 1995). Although Cyp20 is not involved in the import of prep-
Fig. 1. Structure of N. crassa FKBPs. (a) Nucleotide and deduced amino acid sequence of the FKBP11. The codons initially identified as being part of the first intron sequence
but that in fact are the beginning of the second exon sequence are in bold. (b) Main characteristics of the fkbp genes. The molecular weight of FKBP22 has been published
previously; the predicted molecular weight of the remaining proteins was calculated using the Molecular Weight Calculator program from EnCor Biotechnology. (c)
Schematic representation of the structures of FKBPs. The numbers indicate the amino acid positions. The scan for multiple domains was performed using the ScanProsite
program. Targeting sequences are shown in black.
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the protein folding machinery as it promotes protein folding in
the mitochondrial matrix in an association with the molecular
chaperones Hsp70 and Hsp60 (Rassow et al., 1995).
In contrast to wild type and the other fkbp mutants, the
fkbp50RIP mutant presented a notorious growth defect whengrown at 26 C (Fig. 4) and also at the lower temperature of
19 C (data not shown). Interestingly, this growth deficiency was
almost completely reversed when the strain was grown at 37 C.
To verify if this phenotype was a result of the fkbp50 disruption
and not a consequence of any secondary effect of the RIPing phe-
nomenon, we tested the Dfkbp50 mutant in the same conditions.
Fig. 2. FKBP50 disruption. (a) Southern blotting analysis of a Neurospora strain transformed with plasmid pFKBP50-X. Genomic DNA from the wild type strain (1) and
transformant T12 (2) was prepared, separately digested with SacI and PvuII, electrophoresed in agarose gels and blotted onto nylon membranes. The filters were probed with
the gene coding for the FKBP50 protein. (b) To identify the mutant, total proteins from N. crassa strains were extracted and analysed by Western blotting using antiserum
against the FKBP50 protein. (c) Restriction map of the gene (P, PvuII; S, SacI; X, XhoI).
Fig. 3. FKBPs localization. (a) Localization of the fusion protein FKBP50::GFP. Conidia from Neurospora strain stably expressing the fusion protein FKBP50::GFP were grown
overnight in minimal medium containing acetate and subsequently analysed by confocal microscopy for the presence of green fluorescence. The nuclei were stained with DRAQ5.
(b) Cellular localization of the FKBPs from N. crassa. Wild type cellular extracts were prepared and the cellular fractions analysed by Western blotting using specific antisera as
indicated in the left side. For the location of the FKBP11 the organelles were purified from the OEFKBP11 strain. The 14 kDa subunit of complex I (CI) was used as control. ET, total
cellular extracts; N, nuclei; M, mitochondria; ER, endoplasmic reticulum; S, components of the cytoplasm after cellular fractionation. In each panel, MT represents total cellular
extracts obtained from null-mutant strains corresponding to the protein being analysed. Approximately 200 lg of protein were loaded in the lanes corresponding to total extracts
and cytoplasm and 50 lg on the others. (For interpretation of color mentioned in this figure the reader is referred to the web version of the article.)
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sensitive phenotype at 26 C that was almost completely over-
turned when the strains were grown at 37 C (Fig. 4b). It is likelythat the cellular stress caused by the heat shock may partially com-
pensate the FKBP50 defect. FKBP50 is homologous to Fpr4 a nucle-
olar protein that consists of an acidic domain in the N-terminus, a
Fig. 4. Effect of the temperature on the growth of different strains of N. crassa. (a) The wild type (h) and mutants Dfkbp11 (e),Dfkbp13 (D) and fkbp22RIP (s) and Dfkbp11/
13/22/50 () were inoculated (5  104 conidia/5 ll) in race tubes with minimal medium and grown at two different temperatures. (b) Growth of fkbp50RIP (e) and Dfkbp50
(D) mutants compared to the wild type (h).
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nus. Recent studies demonstrate that Fpr4 possesses a novel his-
tone chaperone activity, acting as a chromatin component
involved in rDNA silencing (Kuzuhara and Horikoshi, 2004). The
acidic domain is responsible for the histone chaperone activity
while the PPIase domain inhibits this activity (Xiao et al., 2006).
In addition, Fpr4 was described as a histone proline isomerase,
whose activity regulates methylation of lysine 38 in histone H3
and the induction of transcription (Nelson et al., 2006). Based on
the homology of FKBP50 and Fpr4 it is possible that the Neurospora
enzyme is also involved in similar processes. In this way, silencing
of the rDNA and/or the induction of several genes could be the rea-
sons for the partial reversion of the growth defect by temperature
increase, which also results in repression of ribosomal protein
genes (Trotter et al., 2002).
Disruption of all four FKBP immunophilins did not affect the
fungus viability, showing that all these proteins are dispensable
for N. crassa survival (Fig. 4a). With the exception of the multiple
mutants carrying the fkbp50 mutation, which maintained the
growth deficiency, none of the other mutant combinations pre-
sented a detectable phenotype in what concerns growth, tempera-
ture-sensitivity, oxidative stress or the presence of a protein
misfolding inducer (data not shown).
3.4. The OEFKBP11 strain is resistant to high levels of calcium and zinc
As mentioned before, to localize the FKBP11 protein we grew
the wild type strain with various carbon sources (1.5% sucrose,
44 mM sodium acetate and 2% glycerol), different temperatures
(26 and 37 C) and different stress conditions, including starvation,
osmotic stress (1 M NaCl and 1 M sorbitol), oxidative stress (0.5–
2 mMH2O2) and protein misfolding (2.5 mM L-Azetidine-2-carbox-
ylic acid). We also tested for the presence of the FKBP11 during
several stages of vegetative development as mycelium, aerial hy-phae and conidia (data not shown). In none of the conditions tested
we detected the presence of the FKBP11.
Since the FKBP11 is not detected during vegetative develop-
ment of the fungus and the Dfkbp11 mutant shows no visible phe-
notype we decided to test if the overexpression of the FKBP11
conducted to any alteration of the cellular functioning. To that pur-
pose the OEFKBP11 strain was grown in plates containing solid sor-
bose medium (GFS) with different stress conditions induced by
1.5 mM H2O2, 200 lM paraquat, 2.5 mM L-azetidine-2-carboxylic
acid, 50 mM LiCl, 100 mM CaCl2 and 4 mM ZnCl2. Surprisingly,
the OEFKBP11 strain presented a different phenotype when grown
in GFS supplemented with 100 mM CaCl2 and 4 mM ZnCl2. In both
situations the OEFKBP11 strain produced larger colonies when
compared to the wild type strain (Fig. 5). Apparently this pheno-
type is not due to a chloride effect since the strain growing in
50 mM LiCl did not present the same phenotype (Fig. 5). The Ca2+
is one of the most important second messengers as its levels
change in response to many cellular responses. The presence of
the FKBP11 appears to give an advantage to the strain, indicating
that the FKBP11 could make part of a specific cellular mechanism.
However, linear growth in race tubes is comparable in strains, wild
type and OEFKBP11, in media containing CaCl2 and ZnCl2 (data not
shown).
To test if these stress agents induce the expression of the
FKBP11 we grew the wild type and the OEFKBP11 strains in liquid
minimal medium supplemented with 100 mM CaCl2 and 4 mM
ZnCl2. The OEFKBP11 showed an increased in the expression of
the FKBP11 in media containing CaCl2 when compared to the con-
trol and media containing ZnCl2 (Fig. 6). Interestingly, the FKBP11
was detected in the wild type growing with CaCl2, but not when
this strain was grown with ZnCl2 (Fig. 6). Since the FKBP11 protein
is not detected during vegetative development of the fungus and
the OFKBP11 strain displays a particular phenotype in media con-
taining high amounts of calcium and zinc we can hypothesize the
Fig. 5. The OEFKBP11 is resistant to high amounts of CaCl2 and ZnCl2. Five microliters of serial dilutions of conidia from the indicated strains was inoculated (spotted) onto
solid sorbose medium (GFS) supplemented with 100 mM CaCl2, 4 mM ZnCl2 or 50 mM LiCl and incubated at 37 C for approximately 24 h.
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nisms. If the protein has an important role in the regulation of
the intracellular levels of calcium or zinc we would expect to de-
tect the protein in the wild type strain growing in the same condi-
tions, which only happen for calcium. However, the amount of
FKBP11 present in any of these situations can probably explain
the phenotype observed for OEFKBP11. The overexpression of the
FKBP11 appears to give an advantage to the strain in some stress
conditions promoting a larger cell proliferation despite that the
protein is not important to the survival of the wild type strain in
the same conditions.
3.5. The FKBP11 is highly expressed during sexual development
Later, we determined that FKBP11 is highly expressed in the
wild type strain growing in Westergaard medium, a medium poor
in nitrogen used to promote sexual development (Fig. 6). We fur-
ther observed that this high expression is not dependent in the
nitrogen concentration but is prevented at 37 C (data not shown),
a condition that also impairs the development of fungal perithecia
(Perkins, 1986). Altogether, these results strongly suggest that
FKBP11 is involved in sexual development. To determine if the
FKBP11 play an important role in the sexual cycle of the fungus
we tested the fertility of the Dfkbp11 mutants (mating-types A
and a) under low-nitrogen conditions. To that propose we crossed
both Dfkbp11 mutants, as female and male, with both wild type
strains. When compared to the wild type, none of the mutants dis-
played any defect related to the development of sexual structures
(formation of protoperithecia and perithecia), producing viableFig. 6. FKBP11 is induced by calcium and in Westergaard medium. The wild type
and the OEFKBP11 strains were grown in minimal medium supplemented with
100 mM CaCl2 or 4 mM ZnCl2. The wild type was also grown in Westergaard
medium (West). Expression of the protein FKBP11 was analysed by Western
blotting using an antiserum against the protein. Approximately 250 lg of protein
were applied in each lane and a mitochondrial complex III polypeptide subunit
(CIII) was used as load control.black ascospores (data not shown). Thus, although the fkbp11 gene
is highly expressed during the sexual development, it appears not
to be a gene essential for the process. As known for other FKBPs
(and cyclophilins) that are involved in multiple cellular processes,
it is possible that the protein encoded by the fkbp11 might have a
redundant function or its absence might be covered by the pres-
ence of other proteins. To date, no gene encoding a FKBP or cyclo-
philin involved in sexual development in filamentous fungi has
been identified. The FKBP11 protein presents some intriguing fea-
tures. Its corresponding gene includes five large introns suggesting
that this might be a highly regulated protein, apparently not nec-
essary for the vegetative development of N. crassa. This much sim-
pler fungal system, as compared with other eukaryotes, will
certainly be very useful for further research on the cellular role
of FKBPs.
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